Submitted URL: http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019101801ashp&r=9372293-2288&l=00c-a60&t=c
Effective URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-rev...
Submission: On October 18 via api from US

Summary

This website contacted 56 IPs in 10 countries across 40 domains to perform 179 HTTP transactions. The main IP is 13.224.196.39, located in Seattle, United States and belongs to AMAZON-02 - Amazon.com, Inc., US. The main domain is www.reuters.com.
TLS certificate: Issued by Amazon on April 2nd 2019. Valid for: a year.
This is the only time www.reuters.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 69.174.55.131 3257 (GTT-BACKB...)
3 13.224.196.39 16509 (AMAZON-02)
13 54.230.95.91 16509 (AMAZON-02)
1 2600:9000:215... 16509 (AMAZON-02)
1 2600:9000:20e... 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
6 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a04:4e42:1b:... 54113 (FASTLY)
1 2a00:1450:400... 15169 (GOOGLE)
1 54.228.221.127 16509 (AMAZON-02)
7 23.45.108.200 20940 (AKAMAI-ASN1)
1 143.204.99.83 16509 (AMAZON-02)
4 13.225.78.43 16509 (AMAZON-02)
10 104.18.136.13 13335 (CLOUDFLAR...)
1 147.75.84.99 54825 (PACKET)
3 2606:4700:20:... 13335 (CLOUDFLAR...)
3 2606:4700::68... 13335 (CLOUDFLAR...)
1 2600:9000:21f... 16509 (AMAZON-02)
3 18.204.31.32 14618 (AMAZON-AES)
1 2600:9000:21f... 16509 (AMAZON-02)
1 143.204.101.109 16509 (AMAZON-02)
1 35.174.78.7 14618 (AMAZON-AES)
2 2a03:2880:f00... 32934 (FACEBOOK)
2 5 23.43.115.95 20940 (AKAMAI-ASN1)
1 2600:1f18:624... 14618 (AMAZON-AES)
1 52.41.107.235 16509 (AMAZON-02)
2 2a03:2880:f10... 32934 (FACEBOOK)
2 2 2a00:1450:400... 15169 (GOOGLE)
2 2 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
8 2.18.235.93 16625 (AKAMAI-AS)
1 13.225.78.67 16509 (AMAZON-02)
1 66.81.204.228 40034 (CONFLUENC...)
4 23.62.140.165 16625 (AKAMAI-AS)
5 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
5 172.217.16.162 15169 (GOOGLE)
1 147.75.100.189 54825 (PACKET)
1 147.75.85.25 54825 (PACKET)
1 2606:4700::68... 13335 (CLOUDFLAR...)
4 2a00:1450:400... 15169 (GOOGLE)
5 199.166.0.26 7415 (ADSAFE-1)
12 2.18.235.40 16625 (AKAMAI-AS)
4 2.21.37.179 20940 (AKAMAI-ASN1)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
5 2.18.232.7 16625 (AKAMAI-AS)
1 172.217.21.198 15169 (GOOGLE)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
2 35.176.11.103 16509 (AMAZON-02)
1 3.8.11.1 16509 (AMAZON-02)
4 199.166.0.32 7415 (ADSAFE-1)
22 104.244.39.20 7415 (ADSAFE-1)
1 2600:9000:200... 16509 (AMAZON-02)
1 2600:9000:20e... 16509 (AMAZON-02)
1 35.165.44.215 16509 (AMAZON-02)
1 2600:9000:215... 16509 (AMAZON-02)
2 2600:9000:215... 16509 (AMAZON-02)
179 56
Apex Domain
Subdomains
Transfer
32 adsafeprotected.com
cdn.adsafeprotected.com
pixel.adsafeprotected.com
static.adsafeprotected.com
dt.adsafeprotected.com
182 KB
17 reuters.com
www.reuters.com
static.reuters.com
wireapi.reuters.com
603 KB
12 media.net
contextual.media.net
cdneast2-xch.media.net
150 KB
10 moatads.com
z.moatads.com
geo.moatads.com
px.moatads.com
mb.moatads.com
303 KB
10 dianomi.com
www.dianomi.com
24 KB
9 teads.tv
a.teads.tv
t.teads.tv
sync.teads.tv
193 KB
8 doubleclick.net
stats.g.doubleclick.net
securepubads.g.doubleclick.net
ad.doubleclick.net
105 KB
8 evidon.com
c.evidon.com
iabmap.evidon.com
36 KB
6 googlesyndication.com
pagead2.googlesyndication.com
tpc.googlesyndication.com
117 KB
6 google-analytics.com
www.google-analytics.com
64 KB
5 moatpixel.com
reutersdfpcw319687550988.s.moatpixel.com
2 KB
5 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 s-onetag.com
get.s-onetag.com
beacon.s-onetag.com
dfp-gateway.s-onetag.com
20 KB
4 googletagservices.com
www.googletagservices.com
101 KB
3 google.de
www.google.de
adservice.google.de
1 KB
3 google.com
www.google.com
adservice.google.com
2 KB
3 consensu.org
vendorlist.consensu.org
evidon.mgr.consensu.org
cmp.teads.mgr.consensu.org
17 KB
3 betrad.com
l.betrad.com
360 B
3 tinypass.com
experience.tinypass.com
cdn.tinypass.com
118 KB
3 tru.am
tru.am
beacon.tru.am
13 KB
3 hotjar.com
static.hotjar.com
script.hotjar.com
vars.hotjar.com
75 KB
3 reutersmedia.net
s4.reutersmedia.net
s1.reutersmedia.net
225 KB
3 chartbeat.com
static.chartbeat.com
mab.chartbeat.com
31 KB
2 2mdn.net
gcdn.2mdn.net
r3---sn-4g5e6nsr.c.2mdn.net
612 B
2 facebook.com
www.facebook.com
349 B
2 segment.io
api.segment.io
282 B
2 facebook.net
connect.facebook.net
87 KB
2 reuters.tv
queso-cdn.prod.reuters.tv
sope.prod.reuters.tv
26 KB
1 cloudflare.com
cdnjs.cloudflare.com
2 KB
1 mnet-ad.net
s.mnet-ad.net
355 B
1 native.ai
cdn.native.ai
43 KB
1 segment.com
cdn.segment.com
71 KB
1 admantx.com
async01.admantx.com
363 B
1 ytimg.com
s.ytimg.com
9 KB
1 youtube.com
www.youtube.com
1 KB
1 googletagmanager.com
www.googletagmanager.com
74 KB
1 bulletinhealthcare.com
mailview.bulletinhealthcare.com
446 B
0 chartbeat.net Failed
ping.chartbeat.net Failed
0 demdex.net Failed
dpm.demdex.net Failed
0 globalwebindex.net Failed
gwiqcdn.globalwebindex.net Failed
179 40
Domain Requested by
22 dt.adsafeprotected.com www.reuters.com
10 www.dianomi.com static.reuters.com
www.dianomi.com
www.reuters.com
10 static.reuters.com www.reuters.com
8 contextual.media.net static.reuters.com
contextual.media.net
www.reuters.com
7 c.evidon.com static.reuters.com
c.evidon.com
6 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
www.reuters.com
5 reutersdfpcw319687550988.s.moatpixel.com www.reuters.com
5 pixel.adsafeprotected.com cdn.adsafeprotected.com
www.reuters.com
5 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.reuters.com
5 sb.scorecardresearch.com 2 redirects www.reuters.com
4 static.adsafeprotected.com pixel.adsafeprotected.com
www.reuters.com
4 px.moatads.com www.reuters.com
4 t.teads.tv www.reuters.com
4 a.teads.tv www.reuters.com
a.teads.tv
4 tpc.googlesyndication.com securepubads.g.doubleclick.net
4 www.googletagservices.com contextual.media.net
securepubads.g.doubleclick.net
4 cdneast2-xch.media.net www.reuters.com
4 wireapi.reuters.com static.reuters.com
3 z.moatads.com securepubads.g.doubleclick.net
a.teads.tv
3 l.betrad.com www.reuters.com
3 www.reuters.com static.reuters.com
www.googletagmanager.com
2 dfp-gateway.s-onetag.com get.s-onetag.com
2 geo.moatads.com z.moatads.com
2 pagead2.googlesyndication.com securepubads.g.doubleclick.net
www.reuters.com
2 www.google.de www.reuters.com
2 www.google.com 2 redirects
2 stats.g.doubleclick.net 2 redirects
2 www.facebook.com www.reuters.com
www.googletagmanager.com
2 api.segment.io cdn.segment.com
2 connect.facebook.net cdn.segment.com
connect.facebook.net
2 experience.tinypass.com www.reuters.com
cdn.tinypass.com
2 tru.am www.googletagmanager.com
tru.am
2 s4.reutersmedia.net www.reuters.com
2 static.chartbeat.com www.reuters.com
1 beacon.s-onetag.com get.s-onetag.com
1 get.s-onetag.com www.googletagmanager.com
1 mb.moatads.com z.moatads.com
1 r3---sn-4g5e6nsr.c.2mdn.net www.reuters.com
1 gcdn.2mdn.net 1 redirects
1 ad.doubleclick.net a.teads.tv
1 sync.teads.tv a.teads.tv
1 cmp.teads.mgr.consensu.org a.teads.tv
1 cdnjs.cloudflare.com www.dianomi.com
1 vars.hotjar.com static.hotjar.com
1 script.hotjar.com static.hotjar.com
1 adservice.google.com www.googletagservices.com
1 adservice.google.de www.googletagservices.com
1 s.mnet-ad.net www.reuters.com
1 cdn.adsafeprotected.com contextual.media.net
1 s1.reutersmedia.net www.reuters.com
1 sope.prod.reuters.tv static.reuters.com
1 beacon.tru.am tru.am
1 evidon.mgr.consensu.org c.evidon.com
1 cdn.tinypass.com experience.tinypass.com
1 cdn.native.ai www.reuters.com
1 vendorlist.consensu.org c.evidon.com
1 iabmap.evidon.com c.evidon.com
1 static.hotjar.com www.googletagmanager.com
1 cdn.segment.com www.reuters.com
1 async01.admantx.com static.reuters.com
1 s.ytimg.com www.youtube.com
1 mab.chartbeat.com static.chartbeat.com
1 www.youtube.com www.reuters.com
1 www.googletagmanager.com www.reuters.com
1 queso-cdn.prod.reuters.tv www.reuters.com
1 mailview.bulletinhealthcare.com 1 redirects
0 ping.chartbeat.net Failed
0 dpm.demdex.net Failed www.reuters.com
0 gwiqcdn.globalwebindex.net Failed www.reuters.com
179 69
Subject Issuer Validity Valid
www.reuters.com
Amazon
2019-04-02 -
2020-05-02
a year crt.sh
static.reuters.com
Amazon
2018-11-28 -
2019-12-28
a year crt.sh
*.chartbeat.com
Gandi Standard SSL CA 2
2019-04-10 -
2020-04-10
a year crt.sh
*.prod.reuters.tv
Amazon
2019-01-28 -
2020-02-28
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.google.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
f6.shared.global.fastly.net
GlobalSign CloudSSL CA - SHA256 - G3
2019-10-17 -
2020-08-07
10 months crt.sh
*.admantx.com
SSL.com RSA SSL subCA
2019-03-29 -
2021-06-25
2 years crt.sh
*.evidon.com
DigiCert ECC Secure Server CA
2019-02-01 -
2020-05-02
a year crt.sh
*.segment.com
DigiCert SHA2 Secure Server CA
2019-06-24 -
2020-07-01
a year crt.sh
wireapi.reuters.com
Amazon
2019-01-01 -
2020-02-01
a year crt.sh
ssl424245.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-30 -
2020-03-07
6 months crt.sh
static.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
ssl389962.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-09-11 -
2020-03-19
6 months crt.sh
*.tinypass.com
DigiCert SHA2 Secure Server CA
2019-01-31 -
2020-03-20
a year crt.sh
l.betrad.com
Go Daddy Secure Certificate Authority - G2
2019-04-25 -
2021-06-24
2 years crt.sh
vendorlist.consensu.org
Amazon
2019-03-06 -
2020-04-06
a year crt.sh
cdn.native.ai
Amazon
2019-08-26 -
2020-09-26
a year crt.sh
evidon.mgr.consensu.org
Amazon
2019-08-22 -
2020-09-22
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-09-22 -
2019-12-20
3 months crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
www.google.de
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.media.net
DigiCert SHA2 Secure Server CA
2018-12-30 -
2020-03-30
a year crt.sh
*.adsafeprotected.com
COMODO RSA Domain Validation Secure Server CA
2018-08-20 -
2020-09-17
2 years crt.sh
*.mnet-ad.net
Sectigo RSA Domain Validation Secure Server CA
2019-04-04 -
2020-04-15
a year crt.sh
*.g.doubleclick.net
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
script.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
vars.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
ssl412106.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-10 -
2020-02-16
6 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
moatads.com
DigiCert ECC Secure Server CA
2018-11-10 -
2020-02-09
a year crt.sh
teads.tv
Let's Encrypt Authority X3
2019-08-22 -
2019-11-20
3 months crt.sh
teads.mgr.consensu.org
Let's Encrypt Authority X3
2019-09-23 -
2019-12-22
3 months crt.sh
*.doubleclick.net
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.c.docs.google.com
GTS CA 1O1
2019-09-10 -
2019-11-19
2 months crt.sh
*.moatads.com
DigiCert SHA2 Secure Server CA
2019-03-12 -
2021-06-10
2 years crt.sh
*.s-onetag.com
Amazon
2019-06-25 -
2020-07-25
a year crt.sh

This page contains 18 frames:

Primary Page: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Frame ID: 4632F67E12AAA4ABB8AA260DEC50D49E
Requests: 156 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 7F5B4C7076F87AC64D2977F3EFCBA682
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=29&https=1&gdpr=1&gdprconsent=0
Frame ID: 8D885910DE6A61304F9B32D68EFBF081
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=102&https=1&gdpr=1&gdprconsent=0
Frame ID: BEC1BA0154E32E5BB1FF878FE840E5C6
Requests: 1 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Frame ID: CB2430B5213FA16C8AC15DBDC23180FE
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
Frame ID: 8EDEC8D7EA1F6FE6AB53854A9EEDFA5F
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
Frame ID: 0004F466F2AAE7BF96411EF399B43FCB
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
Frame ID: 3790D35F2148D4C141707FE67BB44A03
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuKWG3WrDVK5lDWFxUbHOam42jUwu-A41YcjDO78SPmxO46wEQQrQljvE3BIQxLM1szA3xlzxVwahD9KQsO_1oN2nWMIGt1ifqYVc2JxkSJilr3z2ArTMSac6gKQqYIWzyJ4vBES57YUyMq2mihDAAnvDQNMLEdMyEJr3uJ1UyUOVts7q-uZ0MEVnVwE-dd3F93zRt8fe-5pj1ju3CWRy1i2nnXKxixLmKB481nufi0BgYJK8QS6iN77Yr8tlyn6-fsvvkUOFMs3zmsvH4jRXQOpXziT-eEsiLuaWEkWILjTSyri5VV&sai=AMfl-YTE_DaAA_qytl7gZlkVuZbixvYvf7cia_hJA_RU3LZhjmazcoLZB4KZHEV1jpK3zI9vpnc-9LVYr05e8SAeDvrXbT9AemmYHEmqRLqXEg&sig=Cg0ArKJSzPXcjqjpVp1DEAE&adurl=
Frame ID: 7E00E969FD28C645A9D241EAFE082D0E
Requests: 8 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstQh8FzcuBCwc_YM-LKXT6cDz8_mUa8BeKu470B04evii68r7U2-Ou-XFt1cDhkowcWFgi4MuxYBz3tWzEofTd9UQyFmlFFsWGkv1sxKJkyspho1W1GU_4eu4E05Zq2ROR7CVcWO1FXpjbD1JAb2SBxSG3rB44m3VM5pH9cdU33Mj8whMsFHyPlHZFcGwVH_nBBabDrHQmbqZqI82Pe4eZRND5DJPt8kQskoHCaC85xZpWpb-Gxy5B45qMfEEneawCgzL2mPc-q2-Gb2l6KIQUuEE-KsyDarzDJ2G7VP1STV1KMql9Da0sS&sai=AMfl-YTaBGu5HxSlQnRGyggpS3-Hrn5XGq6kux83OIQOCNjMDExXK0lTTLjVbklAN0bXAH7AYn22FKYlkNFZB0VvLS3fWBPJPvxj2v5aPYLhoA&sig=Cg0ArKJSzEc_--wTFz-lEAE&urlfix=1&adurl=
Frame ID: 36201D7236763510F5693639E03059B1
Requests: 5 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=20067072&chanId=21714695662&placementId=5190722610&pubCreative=138290267254&pubOrder=2607453244&cb=822835860&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=
Frame ID: FA621606224BF819BD826D503F0EF7B3
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=21714695662&placementId=5075918839&pubCreative=138206523841&pubOrder=2107429564&cb=1755112793&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=
Frame ID: 88C0941A61604D47167EE793C609A492
Requests: 2 HTTP requests in this frame

Frame: https://cmp.teads.mgr.consensu.org/index.html
Frame ID: 4CEB64D15C7245F906207E83A6EED5A1
Requests: 1 HTTP requests in this frame

Frame: https://sync.teads.tv/iframe?pid=78296&userId=ccb1d7c6-9dd4-47ea-b222-e575ec0ef3e9&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&env=js-web&1571411357485
Frame ID: 202B62ED6606B9E85CC62ED303348D12
Requests: 1 HTTP requests in this frame

Frame: https://a.teads.tv/media/format/v3/assets/default/player-sprite.svg
Frame ID: 5554E50437AC476E532023AC55FA16FA
Requests: 2 HTTP requests in this frame

Frame: data://truncated
Frame ID: 746D52CB51CCF206B7138BB35A5C78DC
Requests: 3 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 9805CDA7B078D925B046A92114979334
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 77D1391EFFF141F375932DD0FFA49B68
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019101801ashp&r=9372293-2288&l=00c-a60&t=c HTTP 302
    https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-g... Page URL

Detected technologies

Overall confidence: 50%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i

Overall confidence: 50%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i

Overall confidence: 100%
Detected patterns
  • script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /googlesyndication\.com\//i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /<!-- (?:End )?Google Tag Manager -->/i

Overall confidence: 100%
Detected patterns
  • script /^\/\/static\.hotjar\.com\/c\/hotjar-/i

Overall confidence: 100%
Detected patterns
  • script /cdn\.segment\.com\/analytics\.js/i

Overall confidence: 100%
Detected patterns
  • html /<iframe[^>]* (?:id="comscore"|scr=[^>]+comscore)|\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i
  • script /\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i

Page Statistics

179
Requests

97 %
HTTPS

47 %
IPv6

40
Domains

69
Subdomains

56
IPs

10
Countries

2916 kB
Transfer

8940 kB
Size

0
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019101801ashp&r=9372293-2288&l=00c-a60&t=c HTTP 302
    https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 55
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1571411352262&ns_c=UTF-8&cv=3.1e&c8=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571411352262&ns_c=UTF-8&cv=3.1e&c8=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&c9=
Request Chain 59
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=161175251.1571411352&jid=1515919191&gjid=1367017152&_gid=1549859104.1571411352&_u=aGDAiEAjR~&z=422115108 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=1515919191&_v=j79&z=422115108 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=1515919191&_v=j79&z=422115108&slf_rd=1&random=1920488587
Request Chain 122
  • https://sb.scorecardresearch.com/p?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571411357122&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=89049821&cs_ucfr=1 HTTP 302
  • https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571411357122&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=89049821&cs_ucfr=1
Request Chain 135
  • https://gcdn.2mdn.net/videoplayback/id/bc01a852ef4f848e/itag/45/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713945394/sparams/id,itag,source,ctier,acao,ip,ipbits,expire/signature/816D9C29FE35A20999331CA06369F61583DA0FD7.86BE94B122C9CB79A2F1A4A53AA8201CB871A0E9/key/ck2/file/file.webm HTTP 302
  • https://r3---sn-4g5e6nsr.c.2mdn.net/videoplayback/id/bc01a852ef4f848e/itag/45/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713945394/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/1F90F7572E7E242222E4415BC5A27EE68122851D.769A58FB06C22F8BF1D45574A704B03BCF3B650F/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5e6nsr/ms/onc/mt/1571411254/mv/m/mvi/2/pl/41/file/file.webm
Request Chain 180
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=161175251.1571411352&jid=34553861&gjid=217391859&_gid=1549859104.1571411352&_u=aGDAiEAjR~&z=1093170591 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=34553861&_v=j79&z=1093170591 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=34553861&_v=j79&z=1093170591&slf_rd=1&random=1679346152

179 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
www.reuters.com/article/us-astrazeneca-cancer-drug-fda/
Redirect Chain
  • http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019101801ashp&r=9372293-2288&l=00c-a60&t=c
  • https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
197 KB
53 KB
Document
General
Full URL
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.39 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-39.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
04315789fc599c6c0e160d7fe93f87196cd87e650858cdbd93ba7658b4a90c85

Request headers

:method
GET
:authority
www.reuters.com
:scheme
https
:path
/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
content-type
text/html;charset=UTF-8
access-control-allow-headers
Access-Control-Allow-Origin,charset
access-control-allow-origin
http://admin.reuters.com
channel-name
healthNews
content-encoding
gzip
date
Fri, 18 Oct 2019 15:09:11 GMT
expires
Fri, 18 Oct 2019 14:58:41 GMT
last-updateda
Thu, 17 Oct 2019 07:20:45 GMT
server
nginx
vary
Accept-Encoding
x-cache
Miss from cloudfront
via
1.1 eab88762658052b4a1e386f8521a38cf.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
U-CzouaV3y7-UsE_2i_MnMCvmuZeeunE1oN1zJ7PH0FrFKMujyqufg==

Redirect headers

Cache-Control
private
Content-Type
text/html; charset=utf-8
Location
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Server
Microsoft-IIS/10.0
Set-Cookie
ASP.NET_SessionId=nkreics3tr0pkj4wcb5t5aif; path=/; HttpOnly
X-AspNet-Version
4.0.30319
X-BNN-Server
biapp1
Date
Fri, 18 Oct 2019 15:09:10 GMT
Content-Length
254
article.bundle.css
static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/
149 KB
16 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/article.bundle.css
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
75852eda135aee3e83ec7e928abee9f276007043fc3285abf75dfc976bae76a7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 13:32:39 GMT
content-encoding
gzip
age
5792
x-cache
Hit from cloudfront
status
200
content-length
16107
last-modified
Wed, 21 Aug 2019 20:48:49 GMT
server
nginx
vary
Accept-Encoding
content-type
text/css
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
cache-control
max-age=7200
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
gnYMwDPJW_CY53TW2DUy46SwR-KzF5CZLyqq3JUzv8ZFWKoNvikD-g==
expires
Fri, 18 Oct 2019 13:43:19 GMT
common.bundle.css
static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/
480 KB
279 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.css
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
8923a55532b21dd8da0ac1ec2c4c353d6371933885994ad46e43728d6b927f68

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 13:57:41 GMT
content-encoding
gzip
last-modified
Wed, 21 Aug 2019 20:48:53 GMT
server
nginx
age
4290
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
d-sMVG5HiWYBrq0EU_mnZCmLO7pVEbGnH1wfoN8yTzM1cmJ4Mq_h4A==
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
expires
Fri, 18 Oct 2019 14:36:27 GMT
chartbeat_mab.js
static.chartbeat.com/js/
19 KB
8 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_mab.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:7000:18:1fcd:349:ca21 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
c1acfa727754dab58bedc79995a642e235c6fde6449824c4fba4318fc060c91c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:08:06 GMT
content-encoding
gzip
last-modified
Wed, 14 Aug 2019 01:44:12 GMT
server
nginx
age
65
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
whs-m0jRsiW-_qcj5DmEA5XvSxjuHRP4vFmBuy-NC2wYUxFSyJPekQ==
via
1.1 9128c49d19c76fd86ec4c647434ccb0a.cloudfront.net (CloudFront)
expires
Fri, 18 Oct 2019 17:08:06 GMT
embedder.bundle.js
queso-cdn.prod.reuters.tv/new/assets/
50 KB
13 KB
Script
General
Full URL
https://queso-cdn.prod.reuters.tv/new/assets/embedder.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:4e00:1e:ef1b:aa40:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
3ad6849c327eac0d747d48c9e8d0430e5599933b668c944154f8228ec48b19ac

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:08 GMT
content-encoding
gzip
x-origin
i-001de507f23474502.queso.prod.us.reuters.tv
age
3
x-cache
Hit from cloudfront
status
200
access-control-allow-origin
*
last-modified
Thu, 21 Mar 2019 19:00:31 GMT
server
nginx/1.14.0 (Ubuntu)
vary
Accept-Encoding
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
via
1.1 0e7eb16f335fe24acf3f13c5dee19c88.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, content-type
x-amz-cf-id
LBKYFSi1v7Ny6rQtQLg8rUiUAQCzZBNeB1QDe8mhmX44FwNlVPn44A==
gtm.js
www.googletagmanager.com/
286 KB
74 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
65e609567b1bb03dfd33de8458722629a7a0ed5c9592bbb405c1ef2f3a508c71
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:11 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
75394
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:11 GMT
3aae9fd5da3557fba61d6444cb943643.png
static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/
1 KB
2 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/3aae9fd5da3557fba61d6444cb943643.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
6346ee09058d555984eb04aac881775c926b5d9d4f73ca91493f7cb708ed90df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 02:01:05 GMT
content-encoding
gzip
age
47286
x-cache
Hit from cloudfront
status
200
content-length
1539
last-modified
Wed, 21 Aug 2019 20:48:46 GMT
server
nginx
vary
Accept-Encoding
content-type
image/png
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
YndWPSb-_DWgnvO_rSCUnMf_--0CFhkZF_Lr7emw0wo307HkzknYOA==
expires
Fri, 18 Oct 2019 17:32:20 GMT
/
s4.reutersmedia.net/resources/r/
755 B
1 KB
Image
General
Full URL
https://s4.reutersmedia.net/resources/r/?m=02&d=20191017&t=2&i=1441765313&r=LYNXMPEF9G0F8&w=20
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
15240dfef1e5d27f80a972bdb8a47b13603079dbb833b52d859466e8d56e23e6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 17 Oct 2019 06:35:51 GMT
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Sun, 17 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Thu, 17 Oct 2019 06:35:49 GMT
server
nginx
x-amz-cf-pop
FRA2
etag
"e3f8f3175d007c482851ca6f481b5087"
x-cache
Hit from cloudfront
x-amz-version-id
1ic9psTqlcJlxHXl9HkBA.2BLsN0u_Dl
status
200
content-type
image/jpeg
content-length
755
x-amz-cf-id
f2vUWbXOuX4-YMJvwQFfIKd8-_AUC64lueZSAM8Vp56cSr6I_J2Mdw==
common.bundle.js
static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/
728 KB
174 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
ee3fd1be0ee04ba7646b79022676abf754827621d364b7957d84682f310da14e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 13:46:03 GMT
content-encoding
gzip
last-modified
Wed, 21 Aug 2019 20:48:53 GMT
server
nginx
age
4988
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
T1ZPKmlmBF9UBDccFgSd4lbDMMF8T6zfOBEtvK1-APDGmjonHSQStQ==
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
expires
Fri, 18 Oct 2019 15:46:03 GMT
article.bundle.js
static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/
360 KB
52 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/article.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
c35c41a7ff7df6d6d0d3e1ba8382602098f32fe9018ee20c827d8b82f7d390e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 13:32:39 GMT
content-encoding
gzip
age
5792
x-cache
Hit from cloudfront
status
200
content-length
52458
last-modified
Wed, 21 Aug 2019 20:48:49 GMT
server
nginx
vary
Accept-Encoding
content-type
application/javascript
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
cache-control
max-age=7200
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
pBLbkthbJFz5qvKoJn13vrmjF589q0OBdOx7Rcb6dv1p1vhXztmq_g==
expires
Sun, 13 Oct 2019 02:38:48 GMT
analytics.js
www.google-analytics.com/
43 KB
18 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
4501
date
Fri, 18 Oct 2019 13:54:10 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
17803
expires
Fri, 18 Oct 2019 15:54:10 GMT
js
www.google-analytics.com/gtm/
60 KB
22 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-TBBXQQ&t=gtm1&cid=161175251.1571411352
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
9e223d43450fc3a047c5eb120c7b38d5ae9b3cf337ffb18352820727dff5dc33
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:11 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
22753
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:11 GMT
iframe_api
www.youtube.com/
859 B
1 KB
Script
General
Full URL
https://www.youtube.com/iframe_api
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
YouTube Frontend Proxy /
Resource Hash
16dd54686a3ed4ca169cba44af157ea072d91930a6b5ad3690b4651820e5e0b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:11 GMT
x-content-type-options
nosniff
server
YouTube Frontend Proxy
content-type
application/javascript
status
200
cache-control
no-cache
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
859
x-xss-protection
0
expires
Tue, 27 Apr 1971 19:44:06 EST
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f01d25f7a76e0682a7a43230c32bef653eaf28b8a6f7a683ebb88bf8c6aa4f50

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d7d62426c6b87d35cef5c2c873355aa44edffcf4a7f927f1c51b10694ea4f6ed

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
71 KB
71 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ee0768f9d2def8b13df284410776f5d755109e77b5c0ca17d8895f65b343a0cd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
/
mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/
206 B
489 B
XHR
General
Full URL
https://mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/?host=reuters.com&domain=reuters.com&path=%2Farticle%2Fus-astrazeneca-cancer-drug-fda-idUSKBN1WW0M8
Requested by
Host: static.chartbeat.com
URL: https://static.chartbeat.com/js/chartbeat_mab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a04:4e42:1b::714 , Ascension Island, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software
/
Resource Hash
e7a5b449db3fff2f120e7685747e5b9e1da46fad4b4bbc6a39d45170018fa8f8

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:11 GMT
content-encoding
gzip
age
2123
x-cache
HIT
status
200
x-cache-hits
1
content-length
168
x-served-by
cache-hhn4037-HHN
access-control-allow-origin
*
x-timer
S1571411352.885529,VS0,VE0
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
content-type
application/json
via
1.1 varnish (Varnish/6.0), 1.1 varnish
cache-control
no-store, no-cache, must-revalidate, max-age=0, s-maxage=0
accept-ranges
bytes
expires
Wed, 16 Oct 2019 14:33:49 GMT
www-widgetapi.js
s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/
23 KB
9 KB
Script
General
Full URL
https://s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/www-widgetapi.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/iframe_api
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
b631fccbe48b26dccef2b6eedeed2d6fb9020daf34dbc8010e587e280b6f498e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 17 Oct 2019 11:35:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
99196
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
8680
x-xss-protection
0
last-modified
Wed, 16 Oct 2019 09:47:41 GMT
server
sffe
vary
Accept-Encoding, Origin
content-type
text/javascript
cache-control
public, max-age=691200
accept-ranges
bytes
timing-allow-origin
https://www.youtube.com
expires
Fri, 25 Oct 2019 11:35:55 GMT
service
async01.admantx.com/admantx/
167 B
363 B
Script
General
Full URL
https://async01.admantx.com/admantx/service?request=%7B%22key%22%3A%22234330834c41105ad5ed794fa036e085b40225c44f9228bb9e2692f427917605%22%2C%20%22decorator%22%3A%22template.reuters%22%2C%20%22filter%22%3A%5B%22default%22%5D%2C%20%22method%22%3A%22descriptor%22%2C%20%22mode%22%3A%22async%22%2C%20%22type%22%3A%22URL%22%2C%20%22body%22%3A%22https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-astrazeneca-cancer-drug-fda%252Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8%22%7D
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.228.221.127 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-228-221-127.eu-west-1.compute.amazonaws.com
Software
nginx/1.12.2 /
Resource Hash
0cfc36510d222641115a1c26859bd49c37be811b7efe7186f13957c43eec7198

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Date
Fri, 18 Oct 2019 15:09:13 GMT
Server
nginx/1.12.2
Connection
keep-alive
Content-Length
167
Content-Type
text/plain; charset=UTF-8
evidon-sitenotice-tag.js
c.evidon.com/sitenotice/
44 KB
12 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
311f7c035bd8e2e36fdef1962231c004e48199087b73427a87499997210bfe16

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
11996
last-modified
Wed, 16 Oct 2019 16:58:44 GMT
server
AkamaiNetStorage
etag
"b42c671932dcdded523f9b56fb2dc206:1571245124"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Sat, 19 Oct 2019 15:09:12 GMT
country.js
c.evidon.com/geo/
264 B
517 B
Script
General
Full URL
https://c.evidon.com/geo/country.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
a9dc8492300a03d1e8b4f4a4be9c834156e846ca94a85b6cf75dddda27f81bb9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
last-modified
Wed, 30 May 2018 22:23:30 GMT
server
AkamaiNetStorage
status
200
etag
"d741ba3b4f067641e5d7c987cbbd763e:1527719010"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
accept-ranges
bytes
access-control-allow-headers
*
content-length
264
snthemes.js
c.evidon.com/sitenotice/1237/
47 KB
4 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/snthemes.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
1dc53ffea32fba15b3dbf3c62f002a18b5835cdd6900e0f6390d85b43d1163a9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
3311
last-modified
Wed, 16 Oct 2019 17:30:35 GMT
server
AkamaiNetStorage
etag
"063550435dc6286e7dd78a739be4bfad:1571247035"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Sat, 19 Oct 2019 15:09:12 GMT
settings.js
c.evidon.com/sitenotice/1237/reuters/
6 KB
2 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/reuters/settings.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
2cccaa9b761c701b19383bf2c16794490c76879fa470dff36fd5052de5485546

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
1781
last-modified
Tue, 15 Oct 2019 18:06:46 GMT
server
AkamaiNetStorage
etag
"c572214fc967df0bb833134036bb5c13:1571162806"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Sat, 19 Oct 2019 15:09:12 GMT
analytics.min.js
cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/
332 KB
71 KB
Script
General
Full URL
https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.99.83 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-99-83.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
86bd33a6a74ca346c85dfb1763c2be1fd48b0e6444815428539fe8f47aee9047

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 11:35:03 GMT
content-encoding
gzip
x-amz-cf-pop
FRA50-C1
x-cache
Hit from cloudfront
status
200
x-amz-replication-status
COMPLETED
content-length
71912
access-control-allow-origin
*
last-modified
Thu, 17 Oct 2019 23:04:04 GMT
server
AmazonS3
etag
"b40b70f3ab0904e1d63cf46940e4c657"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
x-amz-version-id
RCcyV7VNAR1xePZpN1p_FuQ6S9D0Dd1V
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
cache-control
public, max-age=300
accept-ranges
bytes
content-type
text/javascript; charset=utf-8
x-amz-cf-id
elR6dfQrz6ff3mAH05YoNdTBvjkJhDV9j_ZztkLReId1XBee-QvrPA==
finance
wireapi.reuters.com/v7/feed/rcom/us/top-nav/
50 B
508 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.43 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-43.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:04:18 GMT
via
1.1 linkerd, 1.1 2fcedcc055e24d7ac99fbc19ed8fc8ec.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Fri, 18 Oct 2019 15:04:18 GMT
x-amz-cf-pop
FRA2-C2
x-amzn-requestid
c9534f59-39ee-4847-a8e6-b15d50bc5eca
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
Bw4h1FE1oAMFbsQ=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
Q3XYsdU3k4pbfLegVpd-GDdPRkUaUasVHfKg8VL3TvIPUfs-9-fxtg==
x-amzn-remapped-connection
keep-alive
markets
wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/
50 B
508 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/markets?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.43 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-43.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
via
1.1 linkerd, 1.1 2fcedcc055e24d7ac99fbc19ed8fc8ec.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Fri, 18 Oct 2019 15:09:12 GMT
x-amz-cf-pop
FRA2-C2
x-amzn-requestid
c588015f-5b24-4d00-9507-e6437b7eb30d
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
Bw5P0HXWDoEFfgw=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
hT5645byt3P4zr1qFM2HbvOoOACmnBcJ_kU4qi6cYGQikvit_uglIg==
x-amzn-remapped-connection
keep-alive
world
wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/
50 B
508 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/world?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.43 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-43.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:07:50 GMT
via
1.1 linkerd, 1.1 2fcedcc055e24d7ac99fbc19ed8fc8ec.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Fri, 18 Oct 2019 15:07:50 GMT
x-amz-cf-pop
FRA2-C2
x-amzn-requestid
7d6844c4-89e2-459e-b9e3-561626acb9ca
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
Bw5C-GGoDoEFe6A=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
d5QdYlLOxYcd7BdD3KcipOvM6p2aHgLRRjCD6PdcYys6aQ0LSU7DMA==
x-amzn-remapped-connection
keep-alive
politics
wireapi.reuters.com/v7/feed/rcom/us/top-nav/
50 B
506 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/politics?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.43 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-43.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:05:12 GMT
via
1.1 linkerd, 1.1 2fcedcc055e24d7ac99fbc19ed8fc8ec.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Fri, 18 Oct 2019 15:05:12 GMT
x-amz-cf-pop
FRA2-C2
x-amzn-requestid
cb6c4701-5d22-46b4-8cd0-bb847709c1d1
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
Bw4qUFxlDoEF0hg=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
lPtssbA3u7lsg8bWI5e0648lakhruqT528Nd0sytxqIq7IixLb8Pkw==
x-amzn-remapped-connection
keep-alive
contextfeed.js
www.dianomi.com/js/
9 KB
3 KB
Script
General
Full URL
https://www.dianomi.com/js/contextfeed.js?
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/article.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
7a736b2f2091be24fcca895da408ed1bf5b0a66dbc3e27522864fe29652db3c8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
1044
cf-polished
origSize=11527
status
200
x-xss-protection
1; mode=block
last-modified
Wed, 16 Oct 2019 11:34:07 GMT
server
cloudflare
etag
W/"2d07-595057a8e8736"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Fri, 18 Oct 2019 19:09:15 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
527b6ea9aeb49cfa-AMS
cf-bgj
minify
breakingNews
www.reuters.com/assets/
1 B
366 B
Fetch
General
Full URL
https://www.reuters.com/assets/breakingNews?view=json
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.39 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-39.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
01ba4719c80b6fe911b091a7c05124b64eeece964e09c058ef8f9805daca546b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
via
1.1 eab88762658052b4a1e386f8521a38cf.cloudfront.net (CloudFront)
server
nginx
x-amz-cf-pop
FRA2-C1
status
200
x-cache
Miss from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
1
x-amz-cf-id
oSX5yX1HWNZ1ycNPkDDX4yYxjwdAmNP16QVVM5-gqWCyThKbyDl5GA==
expires
Fri, 18 Oct 2019 15:07:48 GMT
/
s4.reutersmedia.net/resources/r/
136 KB
136 KB
Image
General
Full URL
https://s4.reutersmedia.net/resources/r/?m=02&d=20191017&t=2&i=1441765313&r=LYNXMPEF9G0F8&w=1280
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
aefe0bdc75bc4527432f24bd33de6d3cc2693e6f92638c3315c28aa2ffa89302

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 17 Oct 2019 06:35:51 GMT
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Sun, 17 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Thu, 17 Oct 2019 06:35:49 GMT
server
nginx
x-amz-cf-pop
FRA2
etag
"d506ee36b43b4ae6d8ba9ed078ba88a7"
x-cache
Hit from cloudfront
x-amz-version-id
oedvVB45Rtkn6SyFcqEc19voWOmveYlV
status
200
content-type
image/jpeg
content-length
139121
x-amz-cf-id
lJISkPDBeqhXx4e7b1DDkjjLwPf-xNdwxi4xQJ5_HYD9Ms1tlGo-rg==
hotjar-65715.js
static.hotjar.com/c/
5 KB
3 KB
Script
General
Full URL
https://static.hotjar.com/c/hotjar-65715.js?sv=5
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.84.99 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
af04f19939e581612804c3810f1d86f12eb77b91767f36f4725fae1f0c919d25
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
section-io-tag
hotjar
age
14
status
200
section-io-cache
Hit
vary
Accept-Encoding
content-length
2393
server
openresty
cache-control
max-age=60
x-frame-options
SAMEORIGIN
etag
W/c8ae53a6b462802ddf97ab3fb90569c1
access-control-max-age
600
section-io-origin-status
304
access-control-allow-origin
*
x-cache-hit
1
section-io-origin-time-seconds
0.071
section-io-id
1b7db0b53a8f84c4fc6676268d35dfe9
accept-ranges
bytes
content-type
application/javascript
reuters.js
tru.am/scripts/custom/
1 KB
787 B
Script
General
Full URL
https://tru.am/scripts/custom/reuters.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a222 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6f23d93c9b8e3ca26f6fcc6be6a8d087e43a3f5795daa3c61017071642f66f3c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 14 Jun 2018 18:27:56 GMT
server
cloudflare
age
4995
etag
W/"40b7d4de06dae04ec0d6537ef2f54db8"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
527b6e96ab1b59be-VIE
expires
Sat, 19 Oct 2019 15:09:12 GMT
load
experience.tinypass.com/xbuilder/experience/
4 KB
1 KB
Script
General
Full URL
https://experience.tinypass.com/xbuilder/experience/load?aid=TIDovF4cqC
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
bd1dc64fac45e75fffefbd76f176c6ea118ab79b88b3efddc5642d4e7c76d4fe

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
br
cf-cache-status
HIT
age
1301
p3p
CP="NON DSP COR OUR IND"
status
200
x-forwarded-https
on
x-request-id
C6rrkzpZrMn
wn
prod-exp-10-0-6-57
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
accept-encoding
content-type
application/javascript;charset=utf-8
cache-control
public, max-age=1800
cf-ray
527b6e969a7ccbac-VIE
expires
Fri, 18 Oct 2019 15:39:12 GMT
en.js
c.evidon.com/sitenotice/1237/translations/
55 KB
5 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/translations/en.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
42ebce48f38ca99ec71f9cdc53e4555d4d0fbd8bdd1a0740e123e32d1b58502d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
4709
last-modified
Mon, 14 Oct 2019 18:54:07 GMT
server
AkamaiNetStorage
etag
"bcc188e94557debbc19be771b7b3cee8:1571079247"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Sat, 19 Oct 2019 15:09:12 GMT
iabevidonmapping.js
iabmap.evidon.com/
7 KB
3 KB
Script
General
Full URL
https://iabmap.evidon.com/iabevidonmapping.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:d400:10:27b4:f500:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a092021e174c55591059b1000001f762a8f9dfb2620a5ab7a402ded82046192b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 06:14:34 GMT
content-encoding
gzip
last-modified
Tue, 08 Oct 2019 17:18:25 GMT
server
AmazonS3
age
70017
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
x-amz-cf-pop
FRA2-C2
x-amz-cf-id
C2ggLESv8Ok8r5FHoaJPzUG2gWUCO6_SOXkE3fhEMPZ8ybJktr5xwQ==
via
1.1 91ba7c34719cd9c69e0357c149b94b90.cloudfront.net (CloudFront)
evidon-cmp.js
c.evidon.com/sitenotice/
23 KB
7 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-cmp.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
2c0255dc71491f7eb909fabf7c2a4111eb30b4373097086c5bf04e93804057dc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
6652
last-modified
Wed, 16 Oct 2019 16:58:46 GMT
server
AkamaiNetStorage
etag
"cf000373b0fd7b697588ee13bd7024a8:1571245126"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Sat, 19 Oct 2019 15:09:12 GMT
evidon-banner.js
c.evidon.com/sitenotice/
10 KB
3 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-banner.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
06d56458db165cd0ede7a6c23b441e81d0269feac7f8793d582253cc63e9db38

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
2958
last-modified
Wed, 16 Oct 2019 16:58:45 GMT
server
AkamaiNetStorage
etag
"119ff1c01eb744dc72c66e4d7f49b38b:1571245125"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Sat, 19 Oct 2019 15:09:12 GMT
2
l.betrad.com/site/v3/1237/5669/20/1/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/20/1/2/2?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.31.32 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-204-31-32.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Fri, 18 Oct 2019 15:09:13 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
vendorlist.json
vendorlist.consensu.org/
88 KB
17 KB
XHR
General
Full URL
https://vendorlist.consensu.org/vendorlist.json
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:ee00:1:af78:4c0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3e25214e79eab3cf412ea2fec1eee887baf77be4448461d72f2af47ee093128a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 08:59:45 GMT
content-encoding
gzip
vary
Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
age
22168
x-cache
Hit from cloudfront
status
200
access-control-allow-origin
*
last-modified
Fri, 18 Oct 2019 08:50:37 GMT
server
AmazonS3
access-control-max-age
86400
access-control-allow-methods
GET
x-amz-version-id
dDurJJk9w9s3FJNGQzpcI8tyg.M9IFSK
via
1.1 1e498d046330e15095a1a2a958463bf5.cloudfront.net (CloudFront)
cache-control
max-age=259200
x-amz-cf-pop
FRA2-C2
content-type
application/json; charset=utf-8
x-amz-cf-id
SO2eqCC-ETSeWhL1reByFOFhuUDV-83UpOoMTGXqwhKlPAxtJyJtvQ==
61500
l.betrad.com/site/v3/1237/5669/20/1/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/20/1/2/2/61500?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.31.32 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-204-31-32.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Fri, 18 Oct 2019 15:09:13 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
61500
l.betrad.com/site/v3/1237/5669/20/4/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/20/4/2/2/61500?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.204.31.32 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-204-31-32.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Fri, 18 Oct 2019 15:09:13 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
ta-pagesocial-sdk.js
tru.am/scripts/
35 KB
12 KB
Script
General
Full URL
https://tru.am/scripts/ta-pagesocial-sdk.js
Requested by
Host: tru.am
URL: https://tru.am/scripts/custom/reuters.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a222 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
2b8d8ef7fec86e16424f0c6be7f0471a0c29256e074e1336d92876ddb4bc09ff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 18 Apr 2019 03:51:14 GMT
server
cloudflare
age
331
etag
W/"942d5ae1e512ccdf18813550428dd002"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
527b6e96cb2859be-VIE
expires
Sat, 19 Oct 2019 15:09:12 GMT
nativeai.js
cdn.native.ai/js/current/
130 KB
43 KB
Script
General
Full URL
https://cdn.native.ai/js/current/nativeai.js?1571270400000
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.109 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-109.fra50.r.cloudfront.net
Software
nginx / ASP.NET
Resource Hash
bfcea73208d9a1f1a1f89d306cdff89c8d4a8740f0e7ab8b84501c1b86f3fd94

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:12 GMT
Content-Encoding
gzip
Last-Modified
Fri, 12 Jul 2019 21:55:34 GMT
Server
nginx
X-Amz-Cf-Pop
FRA50-C1
X-Powered-By
ASP.NET
Vary
Accept-Encoding
X-Cache
RefreshHit from cloudfront
Content-Type
application/javascript
Via
1.1 055d899361491602a9ef1eb0cdc5e337.cloudfront.net (CloudFront)
Cache-Control
max-age=0,must-revalidate
Transfer-Encoding
chunked
Connection
keep-alive
X-Amz-Cf-Id
lTL-t63ZiVQCfhnFuwrprjkWQgMqlqVFD2ZbG-kA2vHh3i0Vk3krpQ==
ads.js
www.reuters.com/
112 B
514 B
Script
General
Full URL
https://www.reuters.com/ads.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.39 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-39.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
7464555aae6d8d87b77f7170fba1698ff64f7454ded58627ca1819246e9a9969

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
gzip
server
nginx
x-amz-cf-pop
FRA2-C1
status
200
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
116
via
1.1 eab88762658052b4a1e386f8521a38cf.cloudfront.net (CloudFront)
x-amz-cf-id
hVk_nMs5Mh9gPPfuj0B-6aYLGk3GFdWMds1brR0h7vAc7XagPXQ3oQ==
expires
Fri, 18 Oct 2019 15:06:59 GMT
tinypass.min.js
cdn.tinypass.com/api/
365 KB
116 KB
Script
General
Full URL
https://cdn.tinypass.com/api/tinypass.min.js
Requested by
Host: experience.tinypass.com
URL: https://experience.tinypass.com/xbuilder/experience/load?aid=TIDovF4cqC
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
23701a52f9c5cda6e5e672be524540ad509df7348dbee7e11702bacdf8866f69

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
br
cf-cache-status
HIT
age
119
p3p
CP="NON DSP COR OUR IND"
status
200
wn
prod-dash-10-0-1-140
last-modified
Thu, 17 Oct 2019 11:24:44 GMT
server
cloudflare
etag
W/"374221-1571311484000-gzip"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=300
cf-ray
527b6e96daf4cbac-VIE
expires
Fri, 18 Oct 2019 15:14:12 GMT
getcookie
evidon.mgr.consensu.org/iab/
169 B
381 B
Script
General
Full URL
https://evidon.mgr.consensu.org/iab/getcookie
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.78.7 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-78-7.compute-1.amazonaws.com
Software
/
Resource Hash
9b133863146a5f391e8cee0842cafc7498ae89b6f79edbecfc842055342c1fe2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
x-amzn-requestid
51faf4d5-d625-4f89-9ef2-35e14975a198
status
200
content-type
text/javascript
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5da9d598-9b28b13a53914d5246254682;Sampled=0
x-amz-apigw-id
Bw5P0Fl5IAMF5rg=
content-length
169
js
www.google-analytics.com/gtm/
60 KB
22 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-KBK7743&cid=161175251.1571411352
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
605b6328846dedec173402f4dadfaf7bc7fb60b8ae0087f2f9cc03fc44248219
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
22752
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:12 GMT
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
995 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 14:20:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
2919
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
856
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:20:33 GMT
fbevents.js
connect.facebook.net/en_US/
103 KB
23 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f007:8:face:b00c:0:1 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
9404cee30e4489a7ed4d6de2dd92aa8e4386fd5ff1c81ebcea77f581952eac31
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-23=":443"; ma=3600
content-length
22458
x-xss-protection
0
pragma
public
x-fb-debug
9sJEN/uGipZHFsMRqCxrU7qLqU1/C4qdF4MgxJ2cPpjn7HxAOqxCrCsut/ucqzctDLaiEnia51+bH3u63F5HEA==
x-fb-trip-id
2112188456
x-frame-options
DENY
date
Fri, 18 Oct 2019 15:09:12 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
beacon
beacon.tru.am/
0
352 B
Fetch
General
Full URL
https://beacon.tru.am/beacon
Requested by
Host: tru.am
URL: https://tru.am/scripts/ta-pagesocial-sdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a222 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded;charset=UTF-8

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:12 GMT
via
1.1 google
cf-cache-status
DYNAMIC
server
cloudflare
status
200
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Origin
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, private, max-age=0
cf-ray
527b6e976fe48cb6-VIE
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 UTC
beacon.js
sb.scorecardresearch.com/
1 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/beacon.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
76c393f564f53c19e795307e622edc8657a603f7a816c2646385697286d11313

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:12 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=86400
Connection
keep-alive
Content-Length
902
Expires
Sat, 19 Oct 2019 15:09:12 GMT
gwiq.js
gwiqcdn.globalwebindex.net/gwiq/
0
0

execute
experience.tinypass.com/xbuilder/experience/
2 KB
1 KB
XHR
General
Full URL
https://experience.tinypass.com/xbuilder/experience/execute?aid=TIDovF4cqC
Requested by
Host: cdn.tinypass.com
URL: https://cdn.tinypass.com/api/tinypass.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
bb3018b0ecd82b59e2e3ff656d5561c71b2caba8e02437f508aed3ed91b0fcab

Request headers

Accept
*/*
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
content-encoding
br
cf-cache-status
DYNAMIC
p3p
CP="NON DSP COR OUR IND"
status
200
x-forwarded-https
on
x-request-id
CcrskzpBU1C
pragma
no-cache
wn
prod-exp-10-0-1-192
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cf-ray
527b6e978c7fcbac-VIE
expires
Thu, 01 Jan 1970 00:00:00 GMT
312961195854690
connect.facebook.net/signals/config/
280 KB
65 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/312961195854690?v=2.9.5&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f007:8:face:b00c:0:1 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
f0accb42c769145b6d141864835eba045063021590a01aa8bcce348573ebb188
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-23=":443"; ma=3600
content-length
66234
x-xss-protection
0
pragma
public
x-fb-debug
Wuk7ee3N2kgShu6F8TtNTI9cYwX5qhVGtmzvh66gGB3T6EH6q7lLRzWmRT5Y30hSrXPsC7VOWHSihHCaDvRORg==
x-fb-trip-id
2112188456
x-frame-options
DENY
date
Fri, 18 Oct 2019 15:09:12 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
article-recirc
sope.prod.reuters.tv/program/rcom/v1/
12 KB
13 KB
Fetch
General
Full URL
https://sope.prod.reuters.tv/program/rcom/v1/article-recirc?edition=us&pageid=USKBN1WW0M8&modules=rightrail,ribbon,bottom
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:624f:b001:7dda:c8b8:5b29:d2ec Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
0e5271ba33d312f7d2cc180bbec2d00a4ff2869c5e44ee22d9e857aed84b5450

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
seq
2f21ec56-e125-4361-a12c-2116e79777e9

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
x-origin
i-0593a16bfc5146c6e.sope.prod.us.reuters.tv
server
nginx/1.14.0 (Ubuntu)
x-amzn-trace-id
Root=1-5da9d598-12fce10529d5da5569f7b5df
status
200
content-type
application/json
access-control-allow-origin
*
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, seq
content-length
12771
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1571411352262&ns_c=UTF-8&cv=3.1e&c8=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review%20-%20Reuters&c7=https%3A%2F%...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571411352262&ns_c=UTF-8&cv=3.1e&c8=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review%20-%20Reuters&c7=https%3A%2F...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571411352262&ns_c=UTF-8&cv=3.1e&c8=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&c9=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:12 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571411352262&ns_c=UTF-8&cv=3.1e&c8=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&c9=
Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:12 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
p
api.segment.io/v1/
21 B
141 B
XHR
General
Full URL
https://api.segment.io/v1/p
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.41.107.235 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-41-107-235.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Fri, 18 Oct 2019 15:09:13 GMT
access-control-allow-origin
https://www.reuters.com
content-length
21
vary
Origin
content-type
application/json
/
www.facebook.com/tr/
44 B
349 B
Image
General
Full URL
https://www.facebook.com/tr/?id=312961195854690&ev=PageView&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&rl=&if=false&ts=1571411352682&sw=1600&sh=1200&v=2.9.5&r=stable&a=seg&ec=0&o=30&fbp=fb.1.1571411352682.447439270&it=1571411352254&coo=false&rqm=GET
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f107:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:12 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-23=":443"; ma=3600
content-length
44
expires
Fri, 18 Oct 2019 15:09:12 GMT
collect
www.google-analytics.com/
35 B
197 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1488951578&t=pageview&_s=1&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&dp=%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&ul=en-us&de=UTF-8&dt=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAiEAjR~&jid=1515919191&gjid=1367017152&cid=161175251.1571411352&tid=UA-24152976-22&_gid=1549859104.1571411352&cd2=Homepage&cd11=us-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review&cd4=News&cd8=0&cd10=False&cd9=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&cd19=Page%20Load&cd7=Desktop&cd14=USKBN1WW0M8&cd6=U.S.&cd5=Article&cd17=Reuters%20Editorial&cd3=Homepage%20-%20Homepage&cd1=Homepage&cd13=289&cd18=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review&z=1199817808
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 11 Oct 2019 18:49:24 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
591588
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=161175251.1571411352&jid=1515919191&gjid=1367017152&_gid=1549859104.1571411352&_u=aGDAiEAjR~&z=422115108
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=1515919191&_v=j79&z=422115108
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=1515919191&_v=j79&z=422115108&slf_rd=1&random=1920488587
42 B
434 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=1515919191&_v=j79&z=422115108&slf_rd=1&random=1920488587
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:12 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:12 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=1515919191&_v=j79&z=422115108&slf_rd=1&random=1920488587
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
0b9ae0631dc9cb1d12dd2eb240ef07bb.png
static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/
22 KB
9 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/0b9ae0631dc9cb1d12dd2eb240ef07bb.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
9f9104dee58871cdb561e4f139fcf095a2fc1fcb0a7778a964975e6b12059c6a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/article.bundle.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 01:52:10 GMT
content-encoding
gzip
age
47822
x-cache
Hit from cloudfront
status
200
content-length
9050
last-modified
Wed, 21 Aug 2019 20:48:45 GMT
server
nginx
vary
Accept-Encoding
content-type
image/png
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
5u1NDBpYi6jpeClLUuMgK_gEZMjJcweE0zYpuIA76shBY7ri8tq7GQ==
expires
Sat, 19 Oct 2019 00:57:52 GMT
/
static.reuters.com/resources/r/
4 KB
4 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191016&t=2&i=1441549802&r=LYNXMPEF9F1L8&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
293480d669d745e90ba80bca66b43add7fa9e3980be2b29d1ed23f4141bc040f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
zg8XavglG8zM03unY3Y8_xz6IPOLopXP
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Sat, 16 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Wed, 16 Oct 2019 18:02:32 GMT
server
nginx
age
69538
etag
"b6dad9f0991da02ac86fc37a0a3ed91c"
x-cache
Hit from cloudfront
content-type
image/jpeg
status
200
date
Thu, 17 Oct 2019 19:50:14 GMT
x-amz-cf-pop
FRA2
content-length
3696
x-amz-cf-id
BLjhahWI8AISFJurF44bCCYl5F-Bk1l3y70u22Gi3OUTLQftLQLEzQ==
/
static.reuters.com/resources/r/
3 KB
4 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191017&t=2&i=1441849252&r=LYNXMPEF9G0DR&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
fcadc35ec776d5c12b7a11625dba7c7f9cdd497a72bc62f8f83e874ad3405386

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
nBe_D1NQTulaxm5aGqFuY0g.QzLHteUE
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Sun, 17 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Thu, 17 Oct 2019 11:09:58 GMT
server
nginx
age
14065
etag
"943acfdc98956d41f975baaf9b0e8da3"
x-cache
Hit from cloudfront
content-type
image/jpeg
status
200
date
Fri, 18 Oct 2019 11:14:47 GMT
x-amz-cf-pop
FRA2
content-length
3174
x-amz-cf-id
e55AFc46FxRFeexoyweS_z4nXQeYv84qP-MRhbhHQ4unCYLnZidSxw==
/
static.reuters.com/resources/r/
4 KB
4 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191018&t=2&i=1442309975&r=LYNXMPEF9H1EZ&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
aefeaf2a65b3881600aca46f184de15f7ab7e1b00141171c676991445a2945ca

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 13:50:08 GMT
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Mon, 18 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Fri, 18 Oct 2019 13:43:17 GMT
server
nginx
age
4712
etag
"74e7359bd0716941f60ee3d9e51f04bb"
x-cache
Hit from cloudfront
x-amz-version-id
lXvh6Bhcz633blmd8HyyBz9D_e2XkT7T
status
200
x-amz-cf-pop
FRA2
content-type
image/jpeg
content-length
3615
x-amz-cf-id
pwSljn4tfxJ_TlWsy0gV5Li0Xzck2TP4TRd4gwMhyq9ubK1Ho8XacQ==
/
static.reuters.com/resources/r/
3 KB
4 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191018&t=2&i=1442147716&r=LYNXMPEF9H09M&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
3779d4b2fa87600c1fe554d3382682973c42b562bc37165442a042ceed5597ef

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 04:40:50 GMT
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Mon, 18 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Fri, 18 Oct 2019 04:40:47 GMT
server
nginx
age
37407
etag
"4563a10514b58306094e94fefbcea7fa"
x-cache
Hit from cloudfront
x-amz-version-id
gJlJlwO1cPQlHYfciJ1MpYxlCvp5116k
status
200
x-amz-cf-pop
FRA2
content-type
image/jpeg
content-length
3263
x-amz-cf-id
6bRGlmJYl0Z6nsIIv52Ew0mAH29sAVzxz55vPCSHSuiQe3z3q6BF7g==
1566521167044.jpg
s1.reutersmedia.net/resources/images/at/
88 KB
87 KB
Image
General
Full URL
https://s1.reutersmedia.net/resources/images/at/1566521167044.jpg
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
670a6bd86461985226f5ca30eae0ec5f7acc533fe1a04d78f96df82efa73d79d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 03:16:20 GMT
content-encoding
gzip
last-modified
Fri, 23 Aug 2019 00:46:07 GMT
server
nginx
age
42772
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
image/jpeg
status
200
cache-control
max-age=86400
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
zte7NhVD_DGW5_QKX8leir-vEWJvdDEjZk2JwTUzoXZCU__6O0dM5w==
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
expires
Sat, 19 Oct 2019 01:40:26 GMT
/
www.facebook.com/tr/ Frame 7F5B
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f107:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3280
pragma
no-cache
cache-control
no-cache
origin
https://www.reuters.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
accept-encoding
gzip, deflate, br
cookie
fr=0krrAcS9ipSy0lUum..BdqdWY...1.0.BdqdWY.
Origin
https://www.reuters.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
alt-svc
h3-23=":443"; ma=3600
date
Fri, 18 Oct 2019 15:09:13 GMT
bidexchange.js
contextual.media.net/
397 KB
113 KB
Script
General
Full URL
https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cb9d7e7c96dc66db208b86570cda11389daebe5f9df811179532dd0ec4f78586

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=1800
expires
Fri, 18 Oct 2019 15:39:14 GMT
iasPET.1.js
cdn.adsafeprotected.com/
18 KB
6 KB
Script
General
Full URL
https://cdn.adsafeprotected.com/iasPET.1.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.67 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-67.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
12c030f8ade953607bbcff2764f71cc9bba2a907cda26ebb943c928569cab2c2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 07 Oct 2019 18:17:47 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Mon, 07 Oct 2019 18:17:44 GMT
Server
AmazonS3
Age
334281
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/javascript
Via
1.1 edfd22ec6695cdc9d7ac634220af1315.cloudfront.net (CloudFront)
Cache-Control
max-age=604800
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA2-C2
X-Amz-Cf-Id
xSdCrJgPiyWaelWIJFQrS2pAPdD5AuW3uGseDqFZC8Xt5D7w1GPKRw==
tc.js
contextual.media.net/
12 KB
7 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=TB4M82W&size=300x250&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
5d23dafa2c443b2dfaeb848fea20fdfacf73479fa6c6070c01c7f713c40311bd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
6675
expires
Sun, 20 Oct 2019 15:09:14 GMT
tc.js
contextual.media.net/
13 KB
7 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=T645KQG&size=728x90&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
61880e6272da762d94c13369e078e5b16d940c992f64debc61bd56a027cb2638

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
7433
expires
Sun, 20 Oct 2019 15:09:14 GMT
checksync.php
contextual.media.net/ Frame 8D88
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=29&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
contextual.media.net
:scheme
https
:path
/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=29&https=1&gdpr=1&gdprconsent=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
accept-encoding
gzip, deflate, br
cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

status
200
server
Apache
content-type
text/html; charset=UTF-8
set-cookie
gdpr_status=1; Expires=Mon, 20 Apr 2020 15:09:14 GMT; domain=.media.net; Path=/;
x-mnet-hl2
E
vary
Accept-Encoding
content-encoding
gzip
cache-control
max-age=578834
expires
Fri, 25 Oct 2019 07:56:28 GMT
date
Fri, 18 Oct 2019 15:09:14 GMT
content-length
4593
hmmaster.js
contextual.media.net/
19 KB
7 KB
Script
General
Full URL
https://contextual.media.net/hmmaster.js?cid=8CUF1VN4G&p=hb&v=3.1.3&https=1&adt=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cc11628ee489395e239bc94ea6dc8d5b1908e6b957cc5c9a9e05a64793f77e28

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=1800
content-length
7348
expires
Fri, 18 Oct 2019 15:39:14 GMT
px.gif
contextual.media.net/
43 B
193 B
Image
General
Full URL
https://contextual.media.net/px.gif?&ch=1&vn=1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:14 GMT
last-modified
Wed, 19 Jul 2017 10:11:12 GMT
server
Apache
content-type
image/gif
status
200
cache-control
max-age=1209600
accept-ranges
bytes
content-length
43
expires
Fri, 01 Nov 2019 15:09:14 GMT
px.gif
s.mnet-ad.net/
43 B
355 B
Image
General
Full URL
https://s.mnet-ad.net/px.gif?&ch=2&vn=1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
66.81.204.228 , Virgin Islands (British), ASN40034 (CONFLUENCE-NETWORK-INC - Confluence Networks Inc, VG),
Reverse DNS
o1-66-81-204-228.static.o1.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:14 GMT
Last-Modified
Wed, 19 Jul 2017 10:11:12 GMT
Server
Apache
Content-Type
image/gif
Cache-Control
max-age=1209600
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=2, max=55
Content-Length
43
Expires
Fri, 01 Nov 2019 15:09:14 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
43 KB
3 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=267235141*4%7C300x250%7C8CUD609M7%7C976846895%40267235141*29%7C300x250%7C11384%7C31484_123996_15%40267235141*38%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40267235141*51%7C300x250%7C973973%7C11084976%7C0.07%40267235141*59%7C300x250%7C8CUF1VN4G%7C_112891%7C0.07%40267235141*74%7C300x250%7C1113800%7C12209207%40267235141*97%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40267235141*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40267235141*145%7C300x250%7C100600%7C147215%40267235141*172%7C300x250%7C8CUF1VN4G%7C15331955%7C0.06%40267235141*175%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%7C0.01%40267235141*178%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40313743496*4%7C728x90%7C8CUD609M7%7C536231532%40313743496*29%7C728x90~970x250%7C11384%7C31484_123996_2~31484_123996_57%40313743496*38%7C970x250~728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G~313743496_8CUF1VN4G%40313743496*51%7C728x90%7C973973%7C11084975%7C0.69%40313743496*59%7C728x90~970x250%7C8CUF1VN4G%7C_112891~_112891%7C0.07%40313743496*74%7C728x90~970x250%7C1113800%7C12209209~12209209%40313743496*97%7C728x90~970x250%7C8CUF1VN4G%7C313743496_8CUF1VN4G~313743496_8CUF1VN4G%40313743496*122%7C728x90%7C8CUF1VN4G%7C8CUF1VN4G_LKbKv9hpus2aba7C923hUsFj%7C1.22%40313743496*145%7C970x250~728x90%7C100600%7C147214~147214%40313743496*172%7C728x90~970x250%7C8CUF1VN4G%7C15303527~15303527%7C0.06%40313743496*175%7C728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G%7C0.01%40313743496*178%7C728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G%40391166652*4%7C160x600%7C8CUD609M7%7C712281133%40391166652*29%7C300x250~160x600~300x600%7C11384%7C31484_123996_15~31484_123996_9~31484_123996_10%40391166652*38%7C300x600~160x600~300x250%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40391166652*51%7C300x250~160x600~300x600%7C973973%7C11084976~11084976~11084976%7C0.07%40391166652*59%7C300x250~160x600~300x600%7C8CUF1VN4G%7C_112891~_112891~_112891%7C0.07%40391166652*74%7C300x250~300x600%7C1113800%7C12209207~12209207%40391166652*97%7C300x250~300x600~160x600%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40391166652*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40391166652*145%7C300x600~160x600~300x250%7C100600%7C147215~147215~147215%40391166652*172%7C160x600~300x250~300x600%7C8CUF1VN4G%7C15331955~15331955~15331955%7C0.06%40391166652*175%7C300x600~160x600~300x250%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%7C0.01%40391166652*178%7C300x600~300x250~160x600%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40451439109*4%7C300x250%7C8CUD609M7%7C155187763%40451439109*29%7C300x250%7C11384%7C31484_123998_15%40451439109*38%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40451439109*51%7C300x250%7C973973%7C11084979%7C0.07%40451439109*59%7C300x250%7C8CUF1VN4G%7C_112891%7C0.07%40451439109*97%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40451439109*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40451439109*145%7C300x250%7C100600%7C147218%40451439109*172%7C300x250%7C8CUF1VN4G%7C15331958%7C0.06%40451439109*175%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%7C0.01%40451439109*178%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40612341223*4%7C728x90%7C8CUD609M7%7C813012502%40612341223*29%7C728x90~970x250%7C11384%7C31484_123996_2~31484_123996_57%40612341223*38%7C970x250~728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G~612341223_8CUF1VN4G%40612341223*51%7C728x90%7C973973%7C11084975%7C0.69%40612341223*59%7C728x90~970x250%7C8CUF1VN4G%7C_112891~_112891%7C0.07%40612341223*74%7C728x90~970x250%7C1113800%7C12209209~12209209%40612341223*97%7C728x90~970x250%7C8CUF1VN4G%7C612341223_8CUF1VN4G~612341223_8CUF1VN4G%40612341223*122%7C728x90%7C8CUF1VN4G%7C8CUF1VN4G_LKbKv9hpus2aba7C923hUsFj%7C1.22%40612341223*145%7C728x90~970x250%7C100600%7C147214~147214%40612341223*172%7C728x90~970x250%7C8CUF1VN4G%7C15303527~15303527%7C0.06%40612341223*175%7C728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G%7C0.01%40612341223*178%7C728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G&crid=267235141%2C313743496%2C391166652%2C451439109%2C612341223&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=308846435153513801571411354301&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.7711973629339177&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A2514%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&prid=8PRVCXX19&wo=1&isRefresh=0&switch=1&cc=BE&ct=BRUSSELS
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
b8b4bf7ff890db6f07f928a750d99dcbd5e9570f392f9034930e628a6b2a0dac

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Fri, 18 Oct 2019 15:09:14 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
3 KB
1 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=267235141*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C267235141%40313743496*84%7C1x1_T645KQG_1%7C8CUF1VN4G%7C313743496%40391166652*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C391166652%40451439109*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C451439109%40612341223*84%7C1x1_T645KQG_1%7C8CUF1VN4G%7C612341223&crid=267235141%2C313743496%2C391166652%2C451439109%2C612341223&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=727574500037122761571411354306&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.7941924795970932&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A2514%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&at=3&prid=8PRVCXX19&wo=1&cc=BE&ct=BRUSSELS
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
e8406e3fcc98df3d91a9b097237420295d07b90cee376dde59834af2439f2ff0

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Fri, 18 Oct 2019 15:09:14 GMT
checksync.php
contextual.media.net/ Frame BEC1
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=102&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
contextual.media.net
:scheme
https
:path
/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=102&https=1&gdpr=1&gdprconsent=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
accept-encoding
gzip, deflate, br
cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

status
200
server
Apache
content-type
text/html; charset=UTF-8
set-cookie
gdpr_status=1; Expires=Mon, 20 Apr 2020 15:09:14 GMT; domain=.media.net; Path=/;
x-mnet-hl2
E
vary
Accept-Encoding
content-encoding
gzip
cache-control
max-age=578834
expires
Fri, 25 Oct 2019 07:56:28 GMT
date
Fri, 18 Oct 2019 15:09:14 GMT
content-length
4593
gpt.js
www.googletagservices.com/tag/js/
46 KB
15 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
07242e8854853219c437a8b0cc7ce768a6e4a85693ff9de1e6910e764c643642
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"310 / 343 of 1000 / last-modified: 1571336459"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14753
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:14 GMT
integrator.js
adservice.google.de/adsid/
109 B
656 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
656 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/
156 KB
58 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:14 GMT
show_companion_ad.js
pagead2.googlesyndication.com/pagead/
188 KB
70 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/show_companion_ad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
958a8c05292ca234eea083293dc80b1c5e5adb2f2777dd8fd977f4e8da6be028
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 14:29:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
2393
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
71217
x-xss-protection
0
server
cafe
etag
12289559622312614241
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Fri, 18 Oct 2019 15:29:21 GMT
tc.js
contextual.media.net/
15 KB
8 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=TF6129H&size=2x2&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
1c5f973eb7e9ce2290f6feaeacfaa58f5cf3821175316bba1d3adcb24d133a11

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
8074
expires
Sun, 20 Oct 2019 15:09:14 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
1 KB
912 B
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=105651588*141%7C1x1_TF6129H_1%7C8CUF1VN4G%7C105651588_8CUF1VN4G&crid=105651588&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=261447567999420831571411354841&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.47120501425717287&ndec=1&scrsize=1600x1200&taginfo=%7B%22105651588%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1477%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A2514%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&at=3&prid=8PRVCXX19&wo=1&cc=BE&ct=BRUSSELS
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
f8380d0bb27ebceaf7a9f393ce24ac01f2cec3bc16942ea5688b22c586b46a99

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Fri, 18 Oct 2019 15:09:14 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
1 KB
1 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=105651588*4%7C2x2%7C8CUD609M7%7C638433813&crid=105651588&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=311928305324941911571411354841&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.784048862685901&ndec=1&scrsize=1600x1200&taginfo=%7B%22105651588%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1477%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A2514%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&prid=8PRVCXX19&wo=1&isRefresh=0&cc=BE&ct=BRUSSELS
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
d35619debcbceb2b00e15ba7ac016bf643d2ede2b4b26320613579f795bf39dd

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:14 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Fri, 18 Oct 2019 15:09:14 GMT
context.pl
www.dianomi.com/cgi-bin/
2 KB
769 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/context.pl?id=4&h=www.reuters.com
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
9c5e297fea0c6e0d7545d1aa598b7552f7e79fa33d4ef25a14591b174a68c3b3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
application/json; charset=ISO-8859-1
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=600
access-control-allow-credentials
true
cf-ray
527b6eaa289f7311-AMS
x-xss-protection
1; mode=block
expires
Fri, 18 Oct 2019 15:10:15 GMT
modules.c8b73d293ba6e2f7c665.js
script.hotjar.com/
431 KB
73 KB
Script
General
Full URL
https://script.hotjar.com/modules.c8b73d293ba6e2f7c665.js
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-65715.js?sv=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.100.189 Central, Hong Kong, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-8
Software
/
Resource Hash
eb4747d9593a2ff2ae1cd49338bb1d5121c21df7e9bd7e11471ef8dc43dbd1c6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
br
last-modified
Thu, 17 Oct 2019 12:05:37 GMT
status
200
etag
"fd94f49e11a30d7540e1ae15f19b929e"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=31536000
section-io-origin-time-seconds
0.026
section-io-origin-status
200
accept-ranges
bytes
section-io-id
404a32d5233edf1779883f38d35c9eec
content-length
74002
box-74dcf4e32eff343c96838bf3a780ac1d.html
vars.hotjar.com/ Frame CB24
0
0
Document
General
Full URL
https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-65715.js?sv=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.85.25 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-9
Software
/
Resource Hash

Request headers

:method
GET
:authority
vars.hotjar.com
:scheme
https
:path
/box-74dcf4e32eff343c96838bf3a780ac1d.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

status
200
date
Fri, 18 Oct 2019 15:09:18 GMT
content-type
text/html
content-length
808
cache-control
max-age=31536000
content-encoding
br
last-modified
Thu, 17 Oct 2019 10:26:51 GMT
etag
"e97b43816dfbff056689db51ae5cdfc7"
section-io-origin-status
200
section-io-origin-time-seconds
0.053
vary
Accept-Encoding
accept-ranges
bytes
section-io-id
85bd8cf5f9d8c6dbcc2dc054bb8381cc
dianomi-context.css
www.dianomi.com/partner/dianomi/css/
169 B
246 B
Stylesheet
General
Full URL
https://www.dianomi.com/partner/dianomi/css/dianomi-context.css?v=1.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
99781410070a5dd4d753fdb8a46f4272082b5be64541dcfcb1b2d3c4aea09c6c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
2343
cf-polished
origSize=199
status
200
x-xss-protection
1; mode=block
last-modified
Mon, 21 Jan 2019 12:43:41 GMT
server
cloudflare
etag
W/"c7-57ff735e16ce7"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
access-control-allow-origin
*
expires
Fri, 18 Oct 2019 19:09:15 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
527b6eaab8129cfa-AMS
cf-bgj
minify
smartads.epl
www.dianomi.com/ Frame 8EDE
0
0
Document
General
Full URL
https://www.dianomi.com/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
accept-encoding
gzip, deflate, br
cookie
__cfduid=dc89711e08ffcbf7532bdde74062df08a1571411355
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

status
200
date
Fri, 18 Oct 2019 15:09:15 GMT
content-type
text/html; charset=UTF-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
expires
now
pragma
no-cache
cache-control
no-cache,no-store,private
link
</img/a/pss/2649/23.css>;rel=preload;as=style
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
527b6eaac81d9cfa-AMS
content-encoding
br
cf-h2-pushed
</img/a/pss/2649/23.css>
videofeed-combined.js
www.dianomi.com/js/
15 KB
4 KB
Script
General
Full URL
https://www.dianomi.com/js/videofeed-combined.js?id=33
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d31b1f947a51cfdc97520d53eb6610e8abf104e48569fb8069e917ffe5c7a617
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
7195
cf-polished
origSize=20718
status
200
x-xss-protection
1; mode=block
last-modified
Wed, 09 Oct 2019 10:58:47 GMT
server
cloudflare
etag
W/"50ee-594782b536c0d"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Fri, 18 Oct 2019 19:09:15 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
527b6eaab8159cfa-AMS
cf-bgj
minify
recirculation.epl
www.dianomi.com/ Frame 0004
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
accept-encoding
gzip, deflate, br
cookie
__cfduid=dc89711e08ffcbf7532bdde74062df08a1571411355
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

status
200
date
Fri, 18 Oct 2019 15:09:15 GMT
content-type
text/html; charset=utf-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
527b6eaac8259cfa-AMS
content-encoding
br
recirculation.epl
www.dianomi.com/ Frame 3790
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
accept-encoding
gzip, deflate, br
cookie
__cfduid=dc89711e08ffcbf7532bdde74062df08a1571411355
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

status
200
date
Fri, 18 Oct 2019 15:09:15 GMT
content-type
text/html; charset=utf-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
527b6eaac8389cfa-AMS
content-encoding
br
lazyload.iife.min.js
cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/
5 KB
2 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/lazyload.iife.min.js
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:c497 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c514d4fb8244af230a89d2203522c6a67a55a3f161cfd4fca9f53301c0588ff
Security Headers
Name Value
Strict-Transport-Security max-age=15780000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
br
vary
Accept-Encoding
cf-cache-status
HIT
age
16045209
status
200
served-in-seconds
0.028
timing-allow-origin
*
last-modified
Sun, 17 Feb 2019 22:45:49 GMT
server
cloudflare
etag
W/"5c69e41d-14cf"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000; includeSubDomains
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=30672000
cf-ray
527b6eaafd8bcbb0-VIE
expires
Wed, 07 Oct 2020 15:09:15 GMT
dianomi-max-200x38.png
www.dianomi.com/img/
15 KB
15 KB
Image
General
Full URL
https://www.dianomi.com/img/dianomi-max-200x38.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
98c311aa7422fcd7e58a00b053de863d392168102280666046859146b7c27958
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
x-content-type-options
nosniff
cf-cache-status
HIT
age
2106302
cf-polished
origSize=31456
status
200
content-length
15624
x-xss-protection
1; mode=block
last-modified
Tue, 23 May 2017 10:48:47 GMT
server
cloudflare
etag
"7ae0-5502ebb78747a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/png
access-control-allow-origin
*
expires
Mon, 18 Nov 2019 01:09:15 GMT
cache-control
public, max-age=2628000
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
527b6eaac8399cfa-AMS
cf-bgj
imgq:100
pixeltrack.pl
www.dianomi.com/cgi-bin/
77 B
185 B
Image
General
Full URL
https://www.dianomi.com/cgi-bin/pixeltrack.pl?cf=545.4.Reuters%20v3.1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d4fa79afcf5a5cc5a0f12dedaf825f11530e6397d723fe7044cd37ba3c248e57
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:15 GMT
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
image/gif; charset=ISO-8859-1
access-control-allow-origin
*
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
527b6eaac83c9cfa-AMS
content-length
77
x-xss-protection
1; mode=block
expires
Thu, 17 Oct 2019 15:09:15 GMT
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
45610b21279531a97f9566b0f0f8a1d287a45ae4bc6bc545971af5cd7e393cc6

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
ads
securepubads.g.doubleclick.net/gampad/
39 KB
13 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2711141879772207&correlator=897398059479500&output=ldjh&impl=fifs&adsid=NT&eid=21062900&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191018&iu_parts=4735792%2Cus.reuters%2Ctentpoles%2CAdvancingForward%2Carticle&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250%7C300x600%7C1x1%2C728x90%7C970x250%7C970x90%7C1100x100%7C1100x90%7C1100x250%7C1x1%2C320x50%7C2x2%7C1x1%7C1100x375%2C320x50%7C1100x420%7C1100x400%2C300x280&fluid=0%2C0%2Cheight%2Cheight%2C0&prev_scp=type%3Dmpu%26div_id%3D7511372%26pixel_distance%3D400%26articleID%3DUSKBN1WW0M8%26storychannel%3Dmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bearnings-news%26story%3D0%26template%3Darticle%26p_count%3D9%26asset%3Dimage%26mnetDNB%3D1%26mnetPageID%3D1%26mnetCV%3D3%26mnetCC%3DBE%26mnetUGD%3D4%7Ctype%3Dleaderboard%26div_id%3D284033549003857%26articleID%3DUSKBN1WW0M8%26storychannel%3Dmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bearnings-news%26story%3D0%26template%3Darticle%26p_count%3D9%26asset%3Dimage%26mnetDNB%3D1%26mnetPageID%3D2%26mnetCV%3D3%26mnetCC%3DBE%26mnetUGD%3D4%7Ctype%3Dcanvas%26div_id%3D13162545%26pixel_distance%3D400%26articleID%3DUSKBN1WW0M8%26storychannel%3Dmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bearnings-news%26story%3D0%26template%3Darticle%26p_count%3D9%26asset%3Dimage%26mnetDNB%3D1%26mnetPageID%3D6%26mnetCV%3D3%26mnetCC%3DBE%26mnetUGD%3D4%7Ctype%3Dconnatix%26div_id%3D4491972%26pixel_distance%3D20000%26articleID%3DUSKBN1WW0M8%26storychannel%3Dmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bearnings-news%26story%3D0%26template%3Darticle%26p_count%3D9%26asset%3Dimage%7Ctype%3Dbizdev_article_rr2%26div_id%3D12066858%26pixel_distance%3D20000%26articleID%3DUSKBN1WW0M8%26storychannel%3Dmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bearnings-news%26story%3D0%26template%3Darticle%26p_count%3D9%26asset%3Dimage&cust_params=bidxc%3D1%26ntvPlacement%3D1093478%26admant%3Dnone&cookie_enabled=1&bc=31&abxe=1&lmt=1571411355&dt=1571411355388&dlt=1571411351393&idt=3431&frm=20&biw=1585&bih=1200&oid=3&adxs=-12245933%2C-12245933%2C-12245933%2C-12245933%2C-12245933&adys=-12245933%2C-12245933%2C-12245933%2C-12245933%2C-12245933&adks=3070890467%2C815761473%2C4006990631%2C421575194%2C559073166&ucis=1%7C2%7C3%7C4%7C5&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&dssz=71&icsg=2818572480&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x-1%7C0x-1%7C754x0%7C754x0%7C300x-1&msz=300x-1%7C0x-1%7C2x2%7C1100x420%7C300x-1&ga_vid=286668208.1571411355&ga_sid=1571411355&ga_hid=1488951578&fws=132%2C132%2C132%2C132%2C132&ohw=1585%2C1585%2C1585%2C1585%2C1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
e878467b82605c255d0be7d2a6650cc5d83e8d7f9eb5f24925ab7bfdc9ac60f6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
12328
x-xss-protection
0
google-lineitem-id
5190722610,-2,5075918839,-2,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138290267254,-2,138206523841,-2,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:15 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

smartads_video_json.pl
www.dianomi.com/cgi-bin/
3 B
148 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/smartads_video_json.pl?id=4729&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/videofeed-combined.js?id=33
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
cache-control
private, no-cache, no-store, must-revalidate, max-age=0, pre-check=0, post-check=0
access-control-allow-credentials
true
cf-ray
527b6eabca697311-AMS
x-xss-protection
1; mode=block
truncated
/
38 B
38 B
Other
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
52dc24c0429ea6ccc5b579a6da8bb79bf41e471fe5108a62009f3c2e195551c0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/webp
pub
pixel.adsafeprotected.com/services/
984 B
1 KB
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_mpu_7511372_USKBN1WW0M8,s:300.250,p:/4735792/us.reuters/tentpoles/AdvancingForward/article,t:display%7D&slot=%7Bid:canvas_leaderboard_284033549003857_USKBN1WW0M8,s:728.90,p:/4735792/us.reuters/tentpoles/AdvancingForward/article,t:display%7D&slot=%7Bid:dpslot_canvas_13162545_USKBN1WW0M8,s:2.2,p:/4735792/us.reuters/tentpoles/AdvancingForward/article,t:display%7D&slot=%7Bid:dpslot_connatix_4491972_USKBN1WW0M8,s:1100.420,p:/4735792/us.reuters/tentpoles/AdvancingForward/article,t:display%7D&slot=%7Bid:dpslot_bizdev_article_rr2_12066858_USKBN1WW0M8,s:300.280,p:/4735792/us.reuters/tentpoles/AdvancingForward/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=b317b07b-7e6b-a1e0-fe82-4bd880ac9a02&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-astrazeneca-cancer-drug-fda%252Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
3388eca9095619d1d64c253c5fa045a4c18fbec92382b6cdffb9136a05ec387a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:15 GMT
X-Server-Name
app23ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
view
securepubads.g.doubleclick.net/pcs/ Frame 7E00
0
263 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuKWG3WrDVK5lDWFxUbHOam42jUwu-A41YcjDO78SPmxO46wEQQrQljvE3BIQxLM1szA3xlzxVwahD9KQsO_1oN2nWMIGt1ifqYVc2JxkSJilr3z2ArTMSac6gKQqYIWzyJ4vBES57YUyMq2mihDAAnvDQNMLEdMyEJr3uJ1UyUOVts7q-uZ0MEVnVwE-dd3F93zRt8fe-5pj1ju3CWRy1i2nnXKxixLmKB481nufi0BgYJK8QS6iN77Yr8tlyn6-fsvvkUOFMs3zmsvH4jRXQOpXziT-eEsiLuaWEkWILjTSyri5VV&sai=AMfl-YTE_DaAA_qytl7gZlkVuZbixvYvf7cia_hJA_RU3LZhjmazcoLZB4KZHEV1jpK3zI9vpnc-9LVYr05e8SAeDvrXbT9AemmYHEmqRLqXEg&sig=Cg0ArKJSzPXcjqjpVp1DEAE&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 18 Oct 2019 15:09:15 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:15 GMT
abg_lite.js
tpc.googlesyndication.com/pagead/js/r20191015/r20110914/ Frame 7E00
30 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20191015/r20110914/abg_lite.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ff2e8d7d164d98cb0dd71282747c6d718236e79036bc2d3f3fecf10d9abb2872
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 15 Oct 2019 14:42:24 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
260811
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
11471
x-xss-protection
0
server
cafe
etag
8177752728920464164
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Oct 2019 14:42:24 GMT
window_focus.js
tpc.googlesyndication.com/pagead/js/r20191015/r20110914/client/ Frame 7E00
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20191015/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 17 Oct 2019 12:21:27 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
96468
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Thu, 31 Oct 2019 12:21:27 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 7E00
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f820f689e79fe927155372514936423b30eb400c1d2b87b6503d1398f6d352c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571051767941600"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29551
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:15 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 7E00
297 KB
100 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
bbc989c438d26daa1365226e9b54996ea19e58ef1862a7aad426b3f66ebffefc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:17 GMT
Content-Encoding
gzip
Last-Modified
Thu, 17 Oct 2019 13:40:25 GMT
Server
AmazonS3
x-amz-request-id
B7B92664311AD361
ETag
"6e3b21308c178d60d826fa0f9c12df6e"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=31644
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101524
x-amz-id-2
CxhHRPuJ0aL7wKsSPc2fmGA9uCc/nqEp3FcLWCUZ+P3pEJ+qkS41IwZokjaTgwacvrHYdso+Opo=
10661177012663494271
tpc.googlesyndication.com/simgad/ Frame 7E00
34 KB
34 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/10661177012663494271
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
d465e4d0705ed60a2fdbd522cdf629fa3e14791233144e4b9465fd5639adabfc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 10 Oct 2019 05:05:55 GMT
x-content-type-options
nosniff
age
727400
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35127
x-xss-protection
0
last-modified
Sun, 06 Oct 2019 11:28:21 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 09 Oct 2020 05:05:55 GMT
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f425f66d90f1150499b36ab47b56fa6fb1a68136e4f42befca20a920ff85306b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571051767941600"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29055
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:15 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 3620
0
255 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstQh8FzcuBCwc_YM-LKXT6cDz8_mUa8BeKu470B04evii68r7U2-Ou-XFt1cDhkowcWFgi4MuxYBz3tWzEofTd9UQyFmlFFsWGkv1sxKJkyspho1W1GU_4eu4E05Zq2ROR7CVcWO1FXpjbD1JAb2SBxSG3rB44m3VM5pH9cdU33Mj8whMsFHyPlHZFcGwVH_nBBabDrHQmbqZqI82Pe4eZRND5DJPt8kQskoHCaC85xZpWpb-Gxy5B45qMfEEneawCgzL2mPc-q2-Gb2l6KIQUuEE-KsyDarzDJ2G7VP1STV1KMql9Da0sS&sai=AMfl-YTaBGu5HxSlQnRGyggpS3-Hrn5XGq6kux83OIQOCNjMDExXK0lTTLjVbklAN0bXAH7AYn22FKYlkNFZB0VvLS3fWBPJPvxj2v5aPYLhoA&sig=Cg0ArKJSzEc_--wTFz-lEAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 18 Oct 2019 15:09:15 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:15 GMT
tag
a.teads.tv/page/44349/ Frame 3620
3 KB
1 KB
Script
General
Full URL
https://a.teads.tv/page/44349/tag
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.179 , France, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-21-37-179.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
12c3ee90c8baac6128d71164f6bea263db63ba2f418ce600f144b6e3d56e915b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:16 GMT
content-encoding
gzip
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, must-revalidate, max-age=3600
access-control-allow-credentials
true
content-length
993
expires
Fri, 18 Oct 2019 16:09:16 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 3620
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f820f689e79fe927155372514936423b30eb400c1d2b87b6503d1398f6d352c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571051767941600"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29551
x-xss-protection
0
expires
Fri, 18 Oct 2019 15:09:15 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 3620
297 KB
100 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
bbc989c438d26daa1365226e9b54996ea19e58ef1862a7aad426b3f66ebffefc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:17 GMT
Content-Encoding
gzip
Last-Modified
Thu, 17 Oct 2019 13:40:25 GMT
Server
AmazonS3
x-amz-request-id
B7B92664311AD361
ETag
"6e3b21308c178d60d826fa0f9c12df6e"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=31644
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101524
x-amz-id-2
CxhHRPuJ0aL7wKsSPc2fmGA9uCc/nqEp3FcLWCUZ+P3pEJ+qkS41IwZokjaTgwacvrHYdso+Opo=
truncated
/ Frame 7E00
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
de28b8670ced4d28e8cadc48c47855bfb9c5e2fe412dd536129112bc42cd8228

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame FA62
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=20067072&chanId=21714695662&placementId=5190722610&pubCreative=138290267254&pubOrder=2607453244&cb=822835860&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
fca06ecbdbe09e952aba907d7c78ad0d3f5ca1c7a6bd433d93f798d611b3d35c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:18 GMT
Content-Encoding
gzip
X-Server-Name
app56ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
truncated
/ Frame 3620
215 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
3c5e68cee714a7b14b128075f3a7d3f5bc10f04964f3cfaf8eeb852b1d872f6f

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame 88C0
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=21714695662&placementId=5075918839&pubCreative=138206523841&pubOrder=2107429564&cb=1755112793&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
d403384c83739790635f246a70200fdf3dd3bd29de7ea5ef71ed80efa4a1d666

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:19 GMT
Content-Encoding
gzip
X-Server-Name
app56ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
teads-format.min.js
a.teads.tv/media/format/v3/
708 KB
184 KB
Script
General
Full URL
https://a.teads.tv/media/format/v3/teads-format.min.js
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/page/44349/tag
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.179 , France, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-21-37-179.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
31f8fa4fe9c5a6f48ef372f820692a8748fb1de140045141b930cd85677399ca

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:17 GMT
content-encoding
gzip
last-modified
Fri, 18 Oct 2019 09:15:03 GMT
x-amz-request-id
8B9641222D5D6296
etag
"050bbd7ce5c6fdd041690525209d3394"
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
status
200
cache-control
private, must-revalidate, max-age=600
x-bucket
9
accept-ranges
bytes
content-length
187940
x-amz-id-2
WSjZNi46OifgfcXTMtT4fcCQq3dn9nx3fSavevw8UFHpmFHbvMODKQhlz1AmkMc+FOTcrpWzFgk=
expires
Fri, 18 Oct 2019 15:19:17 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 7E00
42 B
178 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsus_K44LpiRDcsN1C6nrL3UdcIVdywGseHVawDOLEhgNYbLaD92Uh1FOPF3lin0sJo5NxNQ89w4M6KZSpABbGnyx1jTTokjAlf5p5SQww4&sig=Cg0ArKJSzCXIa92-qFA1EAE&adk=3070890467&tt=-1&bs=1585%2C1200&mtos=1025,1025,1025,1025,1025&tos=1025,0,0,0,0&p=436,1140,686,1440&mcvt=1025&rs=3&ht=0&tfs=112&tls=1137&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=10&niot_cbk=29&md=2&lm=2&rst=1571411355848&rpt=63&isd=0&msd=0&oseid=3&xdi=0&xosd=1&ps=1600%2C6106&ss=1600%2C1200&pt=-1&bin=1&deb=1-2-2-12-13-13-32-11-0-0-0&tvt=1130&r=v&id=osdim&vs=4&uc=13&upc=0&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x250&itpl=3&v=20191014
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:17 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
index.html
cmp.teads.mgr.consensu.org/ Frame 4CEB
0
0
Document
General
Full URL
https://cmp.teads.mgr.consensu.org/index.html
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:292::2c92 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash

Request headers

Host
cmp.teads.mgr.consensu.org
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

x-amz-id-2
eP74N5mDf2mwuUwz6E0m831egGDvXvr6HEIydDhB20yVDuv4ZE6ina8YQaGiXGlfbz2w11Bw+zo=
x-amz-request-id
93A9209AF986CF84
Last-Modified
Fri, 14 Sep 2018 07:42:32 GMT
ETag
"e7d6c2974a38b7ff77a560e83789f66a"
Accept-Ranges
bytes
Content-Type
text/html
Content-Length
583
Server
AmazonS3
Cache-Control
max-age=300
Expires
Fri, 18 Oct 2019 15:14:17 GMT
Date
Fri, 18 Oct 2019 15:09:17 GMT
Connection
keep-alive
p2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/p?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571411357122&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_s...
  • https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571411357122&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_...
43 B
309 B
Image
General
Full URL
https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571411357122&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=89049821&cs_ucfr=1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
24e480e4659fbae818853a38f8a3036f529f539024dc3e772c0b594ce02ea9db

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:17 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571411357122&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=89049821&cs_ucfr=1
Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:17 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=placementCall&ts=1571411357120&pageId=44349&pid=78296&env=js-web&pfid=[pfid]&f=1&fv=139
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Fri, 18 Oct 2019 15:09:17 GMT
cache-control
max-age=0, no-cache, no-store
expires
Fri, 18 Oct 2019 15:09:17 GMT
content-length
23
content-type
image/gif
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=slotAvailable&ts=1571411357120&pageId=44349&pid=78296&env=js-web&pfid=[pfid]&f=1&slot=native&fv=139
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Fri, 18 Oct 2019 15:09:17 GMT
cache-control
max-age=0, no-cache, no-store
expires
Fri, 18 Oct 2019 15:09:17 GMT
content-length
23
content-type
image/gif
ad
a.teads.tv/page/44349/
46 KB
3 KB
XHR
General
Full URL
https://a.teads.tv/page/44349/ad?windowWidth=1600&windowHeight=1200&windowDepth=1&windowReferrerUrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&page=%7B%22id%22%3A44349%2C%22placements%22%3A%5B%7B%22id%22%3A78296%2C%22validity%22%3A%7B%22status%22%3Atrue%2C%22reasons%22%3A%5B%5D%7D%2C%22player%22%3A%7B%22width%22%3A755%2C%22height%22%3A425%7D%2C%22slotType%22%3A%22native%22%7D%5D%2C%22gdpr_iab%22%3A%7B%22status%22%3A23%2C%22consent%22%3A%22%22%2C%22reason%22%3A230%7D%7D&userId=ccb1d7c6-9dd4-47ea-b222-e575ec0ef3e9&formatVersion=2.22.61&env=js-web&netBw=10&ttfb=66
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.179 , France, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-21-37-179.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
b6ecf2054b75f56ff37d76da6b689868dee46282f1ab0d26e2446513ea49680c

Request headers

Accept
application/json; charset=UTF-8
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:17 GMT
content-encoding
gzip
status
200
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
2734
expires
Fri, 18 Oct 2019 15:09:17 GMT
iframe
sync.teads.tv/ Frame 202B
0
0
Document
General
Full URL
https://sync.teads.tv/iframe?pid=78296&userId=ccb1d7c6-9dd4-47ea-b222-e575ec0ef3e9&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&env=js-web&1571411357485
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
akka-http/10.1.5 /
Resource Hash

Request headers

:method
GET
:authority
sync.teads.tv
:scheme
https
:path
/iframe?pid=78296&userId=ccb1d7c6-9dd4-47ea-b222-e575ec0ef3e9&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&env=js-web&1571411357485
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
accept-encoding
gzip, deflate, br
cookie
tt_viewer=98ea290c-cd6e-43f9-871e-46c44782fc7a
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8

Response headers

status
200
content-type
text/html; charset=UTF-8
server
akka-http/10.1.5
content-length
1694
expires
Fri, 18 Oct 2019 15:09:17 GMT
cache-control
max-age=0, no-cache, no-store
pragma
no-cache
date
Fri, 18 Oct 2019 15:09:17 GMT
set-cookie
tt_exelate=; Expires=Sat, 19 Oct 2019 15:09:17 GMT; Domain=.teads.tv; SameSite=None tt_bluekai=; Expires=Sat, 19 Oct 2019 15:09:17 GMT; Domain=.teads.tv; SameSite=None tt_emetriq=; Expires=Sat, 19 Oct 2019 15:09:17 GMT; Domain=.teads.tv; SameSite=None tt_liveramp=; Expires=Sat, 19 Oct 2019 15:09:17 GMT; Domain=.teads.tv; SameSite=None tt_neustar=; Expires=Sat, 19 Oct 2019 15:09:17 GMT; Domain=.teads.tv; SameSite=None tt_salesforce=; Expires=Sat, 19 Oct 2019 15:09:17 GMT; Domain=.teads.tv; SameSite=None tt_dar=; Expires=Sat, 19 Oct 2019 15:09:17 GMT; Domain=.teads.tv; SameSite=None tt_skp=; Expires=Sat, 19 Oct 2019 15:09:17 GMT; Domain=.teads.tv; SameSite=None
xml;dc_sdk_apis=1,2;dc_omid_p=Teadstv
ad.doubleclick.net/ddm/pfadx/N1181610.3639REUTERS.COM/B23277528.256572085;sz=0x0;ord=CACHEBUSTER;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dcmt=text/
32 KB
9 KB
XHR
General
Full URL
https://ad.doubleclick.net/ddm/pfadx/N1181610.3639REUTERS.COM/B23277528.256572085;sz=0x0;ord=CACHEBUSTER;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dcmt=text/xml;dc_sdk_apis=1,2;dc_omid_p=Teadstv
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.21.198 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s12-in-f198.1e100.net
Software
cafe /
Resource Hash
ae8f2c662669b90cce7c3120b7a9ae6f03767db650ffeb0cf4cf3320925df335
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:17 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
8877
x-xss-protection
0
pragma
no-cache
server
cafe
content-type
text/xml; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=adReceived&ts=1571411357120&pageId=44349&pid=78296&env=js-web&pfid=1&f=1&slot=native&fv=139
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Fri, 18 Oct 2019 15:09:17 GMT
cache-control
max-age=0, no-cache, no-store
expires
Fri, 18 Oct 2019 15:09:17 GMT
content-length
23
content-type
image/gif
player-sprite.svg
a.teads.tv/media/format/v3/assets/default/ Frame 5554
9 KB
4 KB
Image
General
Full URL
https://a.teads.tv/media/format/v3/assets/default/player-sprite.svg
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.179 , France, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-21-37-179.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
3ba7f40e2b4080979389e9b81e6d0ed155e9b7f74b3310bc1289ee70cba2035d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:17 GMT
content-encoding
gzip
last-modified
Thu, 25 Apr 2019 13:56:19 GMT
x-amz-request-id
805BC9E9266715D2
etag
"6a80cb691946e09ba579b0f8456aae28"
vary
Accept-Encoding
content-type
image/svg+xml
status
200
cache-control
private, must-revalidate, max-age=16070400
x-bucket
f
accept-ranges
bytes
content-length
3379
x-amz-id-2
RfD+mamvJfyiNWHInHArisvhYY6wSPsFr8/+QD0AbvX16qyni++GNJtYEiJ3G4h3m2tny8TbsX4=
expires
Tue, 21 Apr 2020 15:09:17 GMT
truncated
/ Frame 5554
669 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
35463ce93e7c820faa404db98d939ff640ae78ca0e29be043861853c9e07c586

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml
moatvideo.js
z.moatads.com/teads245638586802/
309 KB
101 KB
Script
General
Full URL
https://z.moatads.com/teads245638586802/moatvideo.js
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
c524ee5702d9851efe6c0f81ae23760ae5791c677f4d19ee804e905e0e9d3fdd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:17 GMT
Content-Encoding
gzip
Last-Modified
Thu, 17 Oct 2019 13:41:13 GMT
Server
AmazonS3
x-amz-request-id
21956E97CFA8C80A
ETag
"cbb5aaa692b9a9699c6d8886ec2e3948"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=31694
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
103198
x-amz-id-2
V3etHqleCeex5q3omrNbH/GKSRLzKV5YlV0BRQcUyjqgrob+k8t7ee2CZlZ/H9YGh+LlXN3cuas=
truncated
/ Frame 746D
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9d02d662da8a47fb5fb610b545007507b6017028043dbb63cd09ec897d3b9627

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
truncated
/ Frame 746D
715 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=adAvailable-success&ts=1571411357121&pageId=44349&pid=78296&env=js-web&pfid=[pfid]&f=1&gid=378540&sid=[connectionId]&slot=native&fv=139
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Fri, 18 Oct 2019 15:09:17 GMT
cache-control
max-age=0, no-cache, no-store
expires
Fri, 18 Oct 2019 15:09:17 GMT
content-length
23
content-type
image/gif
file.webm
r3---sn-4g5e6nsr.c.2mdn.net/videoplayback/id/bc01a852ef4f848e/itag/45/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713945394/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,m... Frame 746D
Redirect Chain
  • https://gcdn.2mdn.net/videoplayback/id/bc01a852ef4f848e/itag/45/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713945394/sparams/id,itag,source,ctier,acao,ip,ipbits,expire/sign...
  • https://r3---sn-4g5e6nsr.c.2mdn.net/videoplayback/id/bc01a852ef4f848e/itag/45/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713945394/sparams/acao,ctier,expire,id,ip,ipbits,it...
256 KB
0
Media
General
Full URL
https://r3---sn-4g5e6nsr.c.2mdn.net/videoplayback/id/bc01a852ef4f848e/itag/45/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713945394/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/1F90F7572E7E242222E4415BC5A27EE68122851D.769A58FB06C22F8BF1D45574A704B03BCF3B650F/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5e6nsr/ms/onc/mt/1571411254/mv/m/mvi/2/pl/41/file/file.webm
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:63::8 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
gvs 1.0 /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:17 GMT
X-Content-Type-Options
nosniff
Last-Modified
Thu, 26 Sep 2019 11:29:53 GMT
Server
gvs 1.0
Content-Type
video/webm
Content-Range
bytes 0-10153441/10153442
Cache-Control
private, max-age=86400
Connection
close
Accept-Ranges
bytes
Alt-Svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
Content-Length
10153442
Expires
Fri, 18 Oct 2019 15:09:17 GMT

Redirect headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:17 GMT
server
ClientMapServer
status
302
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
https://r3---sn-4g5e6nsr.c.2mdn.net/videoplayback/id/bc01a852ef4f848e/itag/45/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713945394/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/1F90F7572E7E242222E4415BC5A27EE68122851D.769A58FB06C22F8BF1D45574A704B03BCF3B650F/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5e6nsr/ms/onc/mt/1571411254/mv/m/mvi/2/pl/41/file/file.webm
cache-control
no-cache, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
643
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
n.js
geo.moatads.com/
111 B
285 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=cMefD.JTVT&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=REUTERSDFPCW3&hp=1&wf=1&vb=5&cm=42&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571411357801&de=743223590861&m=0&ar=9daef28-clean&iw=42d82ba&q=2&cb=0&ym=0&cu=1571411357801&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=20067072%3A2607453244%3A5190722610%3A138290267254&zMoatTP=mpu&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=21714695662&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=21714695662&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=21714695662&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&id=1&ii=4&zMoatBlacklist=true&bo=3735912&bd=21714695662&dfp=0%2C1&la=21714695662&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=1&na=371558252&cs=0&callback=DOMlessLLDcallback_36074752
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.176.11.103 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-35-176-11-103.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
0ff6f712719994d3d3de8ada614d4cf937256b4345fa7591a5e703802f025a26

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:18 GMT
server
TornadoServer/4.5.3
etag
"277931b51ba67fc83ed09f6b4fa481ab42468ed2"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
111
n.js
geo.moatads.com/
114 B
288 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=cMefD.JTVT&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=REUTERSDFPCW3&hp=1&wf=1&vb=5&cm=42&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571411357801&de=743223590861&m=0&ar=9daef28-clean&iw=42d82ba&q=3&cb=0&ym=0&cu=1571411357801&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=20067072%3A2607453244%3A5190722610%3A138290267254&zMoatTP=mpu&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=21714695662&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=21714695662&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=21714695662&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&id=1&ii=4&zMoatBlacklist=true&bo=3735912&bd=21714695662&dfp=0%2C1&la=21714695662&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=1&na=151842197&cs=0&callback=MoatDataJsonpRequest_36074752
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.176.11.103 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-35-176-11-103.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
56d124b572ecdfb06539b7e7c0a61f12c9ea96c61db1baac0386b78963c596bf

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:18 GMT
server
TornadoServer/4.5.3
etag
"faeb2374409dea9449bc41f1cc85a30dd79b12be"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
114
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=17&i=REUTERSDFPCW3&hp=1&wf=1&vb=5&cm=3&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571411357883&de=152366577945&m=0&ar=9daef28-clean&iw=42d82ba&q=9&cb=0&ym=0&cu=1571411357883&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=54423312%3A2107429564%3A5075918839%3A138206523841&zMoatTP=canvas&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=21714695662&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=21714695662&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=21714695662&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&id=1&ii=4&zMoatBlacklist=true&bo=3735912&bd=21714695662&dfp=0%2C1&la=21714695662&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=1&na=746833343&cs=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:18 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:18 GMT
s.js
mb.moatads.com/
146 B
320 B
Script
General
Full URL
https://mb.moatads.com/s.js?url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&confidence=2&pcode=teads245638586802&callback=BrandSafetyNadoscallback_96489799
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/teads245638586802/moatvideo.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.8.11.1 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-3-8-11-1.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
8fc3fafefcdb8f3dae87edf819d0b6c8f9aed3fcbfef89eec40507ced94c46a8

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 15:09:21 GMT
server
TornadoServer/4.5.3
etag
"578dfff3e68cf27cc61b9eac3febda9ab68283ae"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
146
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=18&fi=1&apd=36&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=20067072&L2id=2607453244&L3id=5190722610&L4id=138290267254&S1id=3735912&S2id=21714695662&ord=1571411357801&r=743223590861&t=meas&bedc=1&q=1&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:18 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:18 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=18&fi=1&apd=36&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=20067072&L2id=2607453244&L3id=5190722610&L4id=138290267254&S1id=3735912&S2id=21714695662&ord=1571411357801&r=743223590861&t=fv&bedc=1&q=2&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:18 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:18 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=175&fi=1&apd=193&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=20067072&L2id=2607453244&L3id=5190722610&L4id=138290267254&S1id=3735912&S2id=21714695662&ord=1571411357801&r=743223590861&t=hdn&bedc=1&q=3&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:18 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:18 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=377&fi=1&apd=395&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=20067072&L2id=2607453244&L3id=5190722610&L4id=138290267254&S1id=3735912&S2id=21714695662&ord=1571411357801&r=743223590861&t=nht&bedc=1&q=4&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:18 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:18 GMT
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=17&i=TEADSVIDEOJS2&hp=1&wf=1&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=8&f=0&j=&t=1571411357897&de=428751633156&m=0&ar=9daef28-clean&iw=32fd9f7&q=13&cb=0&ym=0&cu=1571411357897&ll=2&lm=0&ln=0&r=0&em=0&en=0&d=28857_Saudi%20Tourism%3A115018_Saudi%20Tourism%20-%20Phase%202%20-%20Other%20Markets%3A378540_Saudi%20Tourism%20-%20Phase%202%20-%20Other%20Markets_I%3A362157_ST%20-%20OTHER%20MARKETS%20-%20CANADA&zMoatGSR=1&zMoatWRW=-&zMoatWRH=-&zMoatOrigSlicer1=882&zMoatOrigSlicer2=78296&zMoatTPL=-&zMoat_ad_entity_id=882&zMoat_connection=0_NONE&zMoat_domain=reuters.com&zMoat_subdomain=reuters.com&zMoat_wid=36114&zMoat_pid=-&zMoatGM_NATVID=-&zMoatD_ARTD=-&zMoatD_FQD=-&zMoatD_MPD=-&zMoatD_VTD=-&zMoatSRE=-&zMoatVSD=-&zMoatCustomParams=-&zMoatJS=-&zMoat_connection_entity_id=0&zMoatGSSC=-&zMoatAuctID=90cc1714-e58f-4492-a061-41277c72c6f4&zMoat_sf=-&ph=&pj=standard&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&id=1&ii=4&bo=882&bd=78296&zMoatDomain=reuters.com&zMoatSubdomain=reuters.com&gw=teads245638586802&fd=1&ac=1&it=500&ti=0&ih=1&fs=1&na=903488512&cs=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:18 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:18 GMT
main.19.8.22.js
static.adsafeprotected.com/ Frame FA62
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=20067072&chanId=21714695662&placementId=5190722610&pubCreative=138290267254&pubOrder=2607453244&cb=822835860&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:22 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app50ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=1&tuv=998&tet=1181&fi=1&apd=1199&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=20067072&L2id=2607453244&L3id=5190722610&L4id=138290267254&S1id=3735912&S2id=21714695662&ord=1571411357801&r=743223590861&t=iv&bedc=1&q=5&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:19 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:19 GMT
main.19.8.22.js
static.adsafeprotected.com/ Frame 88C0
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=21714695662&placementId=5075918839&pubCreative=138206523841&pubOrder=2107429564&cb=1755112793&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:22 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app50ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
sca.17.4.95.js
static.adsafeprotected.com/ Frame 9805
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:22 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app50ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x250&pubId=20067072&chanId=21714695662&placementId=5190722610&pubCreative=138290267254&pubOrder=2607453244&cb=822835860&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&adsafe_type=abdfq&adsafe_jsinfo=,id:c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd,c:rpCsPN,sl:inView,em:true,fr:true,mn:app56ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c1|1d|1e|1f|1g1|1h,idMap:1b*,pl:,rend:1,renddet:IMG.qs,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:3168,oid:41fb90c9-f1b9-11e9-810d-382c4ac63189,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:22 GMT
X-Server-Name
app56ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCsPW,pingTime:0,time:3177,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:3177,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[23~100],as:[23~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:22 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCsQ2,pingTime:-2,time:3183,type:a,im:{sf:0,pom:1,prf:{beA:3106,beZ:3107,mfA:6257,cmA:6257,inA:6257,inZ:6262,prA:6262,prZ:6267,si:6274,poA:6274,poZ:6279,cmZ:6279,mfZ:6279,loA:6283,loZ:6285,ltA:6288,ltZ:6288,mdA:3107,mdZ:6251}},sca:{dfp:{df:4,sz:300.250,dom:div}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:3183,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[29~100],as:[29~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1,slid:[google_ads_iframe_/4735792/us.reuters/tentpoles/AdvancingForward/article_0,google_ads_iframe_/4735792/us.reuters/tentpoles/AdvancingForward/article_0__container__,dpslot_mpu_7511372_USKBN1WW0M8,USKBN1WW0M8],sinceFw:14,readyFired:true}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:22 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCsQz,time:3216,type:e,env:{ar:self.0},es:0,sc:1,ha:1,gm:1,slTimes:{i:3216,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[62~100],as:[62~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:22 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
sca.17.4.95.js
static.adsafeprotected.com/ Frame 77D1
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 18 Oct 2019 15:09:22 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app50ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=2x2&pubId=54423312&chanId=21714695662&placementId=5075918839&pubCreative=138206523841&pubOrder=2107429564&cb=1755112793&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&adsafe_type=abdfq&adsafe_jsinfo=,id:1b48b068-7672-7275-fd7a-dcad985a7ba3,c:rpCsQU,sl:inView,em:true,fr:true,mn:app56ami,pt:1-5-15,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,pl:,rend:0,renddet:WINDOW,rmeas:0,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:3209,oid:42010f14-f1b9-11e9-810d-382c4ac63189,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:22 GMT
X-Server-Name
app56ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCsR1,pingTime:0,time:3216,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:3216,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[14~100],as:[14~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:22 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCsR5,pingTime:-2,time:3220,type:a,im:{sf:0,pom:1,prf:{beA:3127,beZ:3128,mfA:6328,cmA:6328,inA:6328,inZ:6330,prA:6330,prZ:6334,si:6336,poA:6336,poZ:6340,cmZ:6340,mfZ:6340,loA:6344,loZ:6345,ltA:6346,ltZ:6346,mdA:3129,mdZ:6299}},sca:{dfp:{df:4,sz:100.100,dom:div},ha1:{res1:1,ps:1,ts:1571411362249,psfr:1}},env:{gca:1,ar:c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd.1},clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:3220,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[18~100],as:[18~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0,slid:[google_ads_iframe_/4735792/us.reuters/tentpoles/AdvancingForward/article_2,google_ads_iframe_/4735792/us.reuters/tentpoles/AdvancingForward/article_2__container__,dpslot_canvas_13162545_USKBN1WW0M8,USKBN1WW0M8],sinceFw:10,readyFired:true}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:22 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCsVi,pingTime:-10,time:3509,type:s,mvn:ZnNjPTEyLHNkPTMsbm89Nyxhc3A9MQ--,fsc:17.4.95v220002022020220000022002222000022220202020222220222220002222022002222200002220222022222222222000220200000022220222220222222222222202222222222222222222222222222222222222200000022022020020000002002202022022022222222000000000020222202022022222000000020000000000000000000002220002220000022200222202220022200200222022202220022222220020222222000220000222202222202222000002002002222222222220022202200022002220222202,sd:MTcuNC45NXYxMjAwfHwxNjAwfHwxfHwxfHwyNHx8MTIwMHx8MHx8MHx8MXx8bGFuZHNjYXBlLXByaW1hcnl8fDI0fHw0LzN8fDQvM3x8MHx8MTYwMA--,no:MTcuNC45NXZNb3ppbGxhfHxOZXRzY2FwZXx8bnx8MTZ8fG58fDB8fG58fExpbnV4IHg4Nl82NHx8R2Vja298fDIwMDMwMTA3fHwtMTIwfHxNb3ppbGxhLzUuMCAoTWFjaW50b3NoOyBJbnRlbCBNYWMgT1MgWCAxMF8xNF81KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvNzQuMC4zNzI5LjE2OSBTYWZhcmkvNTM3LjM2fHwxfHwxfHxHb29nbGUgSW5jLnx8bg--,asp:1571411362511||b28cc5fdaff77dc5b0c524124b881ba0||675c74d5f114ba25a49fb0f4cb02f70f||37bd11281fea10f6f32a13d0af845a29||04accb2faf5bf345a0d4647e53cbd4aa||210feb0ad48ade7a826c9065a525a250||4b1d491d2eba83b9dac451edb8357dc3||3755384206839c5ea89f40193a01b702||1529428597}
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:22 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCt68,pingTime:1,time:4181,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:4182,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1028~100],as:[1028~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:21,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c.10764|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:23 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCt6b,pingTime:1,time:4184,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:4184,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1030~100],as:[1030~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:21,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c.10764|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:23 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCt6c,pingTime:1,time:4185,type:c,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:4185,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1031~100],as:[1031~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:21,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c.10764|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1,metricId:publ1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:23 GMT
X-Server-Name
dt54ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCt6d,pingTime:1,time:4186,type:c,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:4186,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1032~100],as:[1032~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:21,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c.10764|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1,metricId:grpm1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:23 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCt7a,pingTime:1,time:4217,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:4217,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1016~100],as:[1016~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:102,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:23 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCt7b,pingTime:1,time:4218,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:4218,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1016~100],as:[1016~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:102,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:23 GMT
X-Server-Name
dt54ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCt7c,pingTime:1,time:4219,type:c,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:4219,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1017~100],as:[1017~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:102,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0,metricId:publ1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:23 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCt7c,pingTime:1,time:4219,type:c,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:4220,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1018~100],as:[1018~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:102,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0,metricId:grpm1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:23 GMT
X-Server-Name
dt54ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCu8B,pingTime:5,time:8178,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:8178,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5024~100],as:[5024~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:58,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c.10764|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:27 GMT
X-Server-Name
dt54ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCu8C,pingTime:5,time:8179,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:8179,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5025~100],as:[5025~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:58,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c.10764|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:27 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCu9M,pingTime:5,time:8223,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:8223,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[5021~100],as:[5021~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:41,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:27 GMT
X-Server-Name
dt54ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCu9N,pingTime:5,time:8224,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:8224,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[5022~100],as:[5022~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:41,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:27 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=11&i=REUTERSDFPCW3&hp=1&wf=1&vb=5&cm=3&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&k=&bq=0&f=0&j=&t=1571411357883&de=152366577945&m=0&ar=9daef28-clean&iw=42d82ba&q=14&cb=0&ym=0&cu=1571411357883&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=54423312%3A2107429564%3A5075918839%3A138206523841&zMoatTP=canvas&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=21714695662&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=21714695662&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=21714695662&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&id=1&ii=4&zMoatBlacklist=true&bo=3735912&bd=21714695662&dfp=0%2C1&la=21714695662&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=1&na=1912501617&cs=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:27 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:27 GMT
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=25&q=2&hp=1&wf=1&vb=5&kq=1&lo=0&uk=null&pk=0&wk=1&rk=1&tk=1&ak=https%3A%2F%2Ftpc.googlesyndication.com%2Fsimgad%2F10661177012663494271&i=REUTERSDFPCW3&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=cMefD.JTVT&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=6&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&id=1&ii=4&cm=0&f=0&j=&t=1571411357801&de=743223590861&cu=1571411357801&m=15102&ar=9daef28-clean&iw=42d82ba&cb=0&ym=0&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=6406&le=1&lf=353&lg=1&lh=34&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&as=1&ag=15070&an=10043&gi=1&gf=15070&gg=10043&ix=15070&ic=15070&ez=1&ck=1181&kw=998&aj=1&pg=100&pf=100&ib=0&cc=1&bw=15070&bx=10043&ci=1181&jz=998&dj=1&aa=1&ad=14974&cn=9947&gn=1&gk=14974&gl=9947&ik=14974&co=1085&cp=998&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=14888&cd=9860&ah=14888&am=9860&rf=0&re=1&ft=5022&fv=5022&fw=1085&wb=2&cl=0&at=0&d=20067072%3A2607453244%3A5190722610%3A138290267254&zMoatRawSlicer1=3735912&zMoatRawSlicer2=21714695662&zMoatBlacklist=true&bo=3735912&bd=21714695662&gw=reutersdfpcw319687550988&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=21714695662&dfp=0%2C1&la=21714695662&zMoatTP=mpu&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Ftentpoles%2FAdvancingForward%2Farticle&zMoatPixelDistance=400&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=21714695662&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=1&na=332831081&cs=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:32 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Fri, 18 Oct 2019 15:09:32 GMT
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCwJT,pingTime:15,time:18178,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:18178,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[15025~100],as:[15025~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:25,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c.10764|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:37 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c17ff6aa-1a4a-5f90-9bf1-07a77388c8cd&tv={c:rpCwJU,pingTime:15,time:18179,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:3167}],es:0,sc:1,ha:1,gm:1,slTimes:{i:18179,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3167,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[15025~100],as:[15025~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:25,fm:rFgtV23+11|12|13|14|15|16|17|18|19|1a|1b*.10764|1b1|1c.10764|1c1|1d|1e|1f|1g1|1h,idMap:1b*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:37 GMT
X-Server-Name
dt54ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCwKY,pingTime:15,time:18217,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:18217,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[15015~100],as:[15015~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:27,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:37 GMT
X-Server-Name
dt54ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=1b48b068-7672-7275-fd7a-dcad985a7ba3&tv={c:rpCwKZ,pingTime:15,time:18218,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:3209}],es:0,sc:1,ha:1,gm:1,slTimes:{i:18218,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:3208,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[15016~100],as:[15016~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:27,fm:rFgtV2v+11|12|13|14|15|16|17|18|19|1a|1b1|1b2|1c*.10764|1c1|1d|1e|1f|1g1|1h,idMap:1c*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 18 Oct 2019 15:09:37 GMT
X-Server-Name
dt46ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
chartbeat_video.js
static.chartbeat.com/js/
66 KB
23 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_video.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:5c00:18:1fcd:349:ca21 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
88762480fb084c0725cf9c3abde10e540ebf64884fd50a86789b5eb661c38cdd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 13:13:34 GMT
content-encoding
gzip
last-modified
Thu, 01 Aug 2019 01:36:07 GMT
server
nginx
age
6965
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50
x-amz-cf-id
2fYhenmv2z3hzmP7r4E8xmcpUuDQjFPVWiJyK0gjUd4a30wicv8Qzw==
via
1.1 09052d1a6e392e4f4a3fd97bf34a2b24.cloudfront.net (CloudFront)
expires
Fri, 18 Oct 2019 15:13:34 GMT
id
dpm.demdex.net/
0
0

tag.min.js
get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/
41 KB
13 KB
Script
General
Full URL
https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:5800:1f:287:d20a:ce1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a5537aed93100c34cdea277b5b092c37b6de90f11339384634a76a035030f7f0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
B0GnU21j5XMDwAuNEC12S2upHRxtcWd0
content-encoding
gzip
last-modified
Mon, 09 Sep 2019 10:39:51 GMT
server
AmazonS3
age
2405
date
Fri, 18 Oct 2019 14:29:36 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/javascript
status
200
cache-control
max-age=3600
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
HtjVF9xgwXDwqnZptOAiJ03RixAERGI8nvbuiTXsfo776Yie7HBWlg==
via
1.1 42b60ee17f7593fff72ca1cb725d6c9a.cloudfront.net (CloudFront)
collect
www.google-analytics.com/
35 B
327 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1488951578&t=timing&_s=2&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&dp=%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&ul=en-us&de=UTF-8&dt=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&plt=29761&pdt=21&dns=1&rrt=202&srt=65&tcp=52&dit=924&clt=924&_gst=383&_gbt=408&_cst=328&_cbt=376&_u=aGDAiEAjR~&jid=34553861&gjid=217391859&cid=161175251.1571411352&tid=UA-24152976-22&_gid=1549859104.1571411352&cd2=Homepage&cd11=us-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review&cd4=News&cd8=0&cd10=False&cd9=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda%2Fastrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8&cd19=Page%20Load&cd7=Desktop&cd14=USKBN1WW0M8&cd6=U.S.&cd5=Article&cd17=Reuters%20Editorial&cd3=Homepage%20-%20Homepage&cd1=Homepage&cd13=289&cd18=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review&z=180679654
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 11 Oct 2019 14:49:17 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
606023
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=161175251.1571411352&jid=34553861&gjid=217391859&_gid=1549859104.1571411352&_u=aGDAiEAjR~&z=1093170591
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=34553861&_v=j79&z=1093170591
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=34553861&_v=j79&z=1093170591&slf_rd=1&random=1679346152
42 B
434 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=34553861&_v=j79&z=1093170591&slf_rd=1&random=1679346152
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:40 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 18 Oct 2019 15:09:40 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=161175251.1571411352&jid=34553861&_v=j79&z=1093170591&slf_rd=1&random=1679346152
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
i
api.segment.io/v1/
21 B
141 B
XHR
General
Full URL
https://api.segment.io/v1/i
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.165.44.215 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-35-165-44-215.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Fri, 18 Oct 2019 15:09:41 GMT
access-control-allow-origin
https://www.reuters.com
content-length
21
vary
Origin
content-type
application/json
ping
ping.chartbeat.net/
0
0

beacon.min.js
beacon.s-onetag.com/
18 KB
6 KB
Script
General
Full URL
https://beacon.s-onetag.com/beacon.min.js
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:5c00:5:9a4c:9b00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
662fa6bcdf71d8f92e29010d3e2e270e0071e5d19b1d14ce205654a78aa0a7a9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
dQ2IPgbwW_sArXQW0CBb3eN5W57SqoQ0
content-encoding
gzip
last-modified
Thu, 04 Apr 2019 09:35:05 GMT
server
AmazonS3
age
1315
date
Fri, 18 Oct 2019 14:47:49 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=3600
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
9JQ4ccVEDgvZe-wQGPjvK97LjN6v8wIO6BD38gdSbhCSZqC-IxExgw==
via
1.1 ef13dd533b8dc9dcfdc35449cf88f808.cloudfront.net (CloudFront)
5190722610
dfp-gateway.s-onetag.com/1/4735792/
110 B
569 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5190722610
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
c249785389db80243503114f46bee572871297bbe904ebbaf64715ac42432a4d

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 14:50:41 GMT
via
1.1 9ab847fabb8c9edbd39cff57c2a2f4c0.cloudfront.net (CloudFront), 1.1 32e4d419823b7f8df8417a8b18c9602d.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1, FRA50-C1
x-amzn-requestid
5ba3ebe2-27d8-4748-8189-3cd76fd91714
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5da9d141-bc9172e77b61ac8601b04449;Sampled=0
x-amz-apigw-id
Bw2iPGfwyK4Fhvg=
content-length
110
x-amz-cf-id
f40M5vij42rG9Wtqfq5AA1OzHZXpHcpii3yN3IH43cphm4qcPJIp2g==
5075918839
dfp-gateway.s-onetag.com/1/4735792/
119 B
579 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5075918839
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
1469ce4dab8ec9f7506ac192f45056e1b3e6ef639247db13752046e111d723c6

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda/astrazeneca-breast-cancer-treatment-gets-fda-priority-review-idUSKBN1WW0M8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 18 Oct 2019 14:42:48 GMT
via
1.1 ddd91cf4cd1b9310c0aee8953bc042e2.cloudfront.net (CloudFront), 1.1 32e4d419823b7f8df8417a8b18c9602d.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2, FRA50-C1
x-amzn-requestid
f07c581f-b35f-4053-ace5-3767fb088bc2
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5da9cf68-c0db4570d6b574b89c37d150;Sampled=0
x-amz-apigw-id
Bw1YSEiaSK4FvxA=
content-length
119
x-amz-cf-id
VUbMZUMsJyP_UzPWZI5yosNlZl_PUFMCSeI8tFVAZjClG-m9cUEWkA==
id
dpm.demdex.net/
0
0

id
dpm.demdex.net/
0
0

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
gwiqcdn.globalwebindex.net
URL
https://gwiqcdn.globalwebindex.net/gwiq/gwiq.js
Domain
dpm.demdex.net
URL
https://dpm.demdex.net/id?d_visid_ver=4.4.0&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=4579BF7A580A3C6A0A495DAF%40AdobeOrg&d_nsid=0&ts=1571411380855
Domain
ping.chartbeat.net
URL
https://ping.chartbeat.net/ping?h=reuters.com&p=reuters.com%2Farticle%2Fus-astrazeneca-cancer-drug-fda-idUSKBN1WW0M8&u=aKJZ2DGQ0dwCmIvhS&d=reuters.com&g=52639&g0=Homepage&g1=Reuters%20Editorial&g4=Article&n=1&f=00001&c=0&x=0&m=0&y=6406&o=1600&w=1200&j=45&R=1&W=0&I=0&E=0&e=0&r=&b=29761&t=BhoR4cDmBY6UCOAsX6C1Avc6CXiz4k&V=116&i=AstraZeneca%20breast%20cancer%20treatment%20gets%20FDA%20priority%20review%20-%20Reuters&tz=-120&sn=1&sv=D0q3BtDA0CxiuBlM3ChRxV1CyNnXZ&sd=1&im=06679cf0&_
Domain
dpm.demdex.net
URL
https://dpm.demdex.net/id?d_visid_ver=4.4.0&d_fieldgroup=AAM&d_rtbd=json&d_ver=2&d_orgid=4579BF7A580A3C6A0A495DAF%40AdobeOrg&d_nsid=0&d_mid=92087347628943773238657993920165083750&ts=1571411382060
Domain
dpm.demdex.net
URL
https://dpm.demdex.net/id?d_visid_ver=4.4.0&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=4579BF7A580A3C6A0A495DAF%40AdobeOrg&d_nsid=0&d_mid=92087347628943773238657993920165083750&ts=1571411382061

Verdicts & Comments Add Verdict or Comment

226 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate object| analytics object| dataLayer object| google_tag_manager function| postscribe string| GoogleAnalyticsObject function| ga object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| Reuters object| parallelMediaHosts object| tag object| firstScriptTag object| player function| onYouTubeIframeAPIReady function| onPlayerPlaybackQualityChange function| onPlayerReady function| onPlayerStateChange object| player2 function| onYouTubeIframeAPIReady2 function| onPlayerReady2 function| onPlayerPlaybackQualityChange2 function| onPlayerStateChange2 object| player3 function| onYouTubeIframeAPIReady3 function| onPlayerReady3 function| onPlayerPlaybackQualityChange3 function| onPlayerStateChange3 object| player4 function| onYouTubeIframeAPIReady4 function| onPlayerReady4 function| onPlayerPlaybackQualityChange4 function| onPlayerStateChange4 object| player5 function| onYouTubeIframeAPIReady5 function| onPlayerReady5 function| onPlayerPlaybackQualityChange5 function| onPlayerStateChange5 object| player7 function| onYouTubeIframeAPIReady7 function| onPlayerReady7 function| onPlayerPlaybackQualityChange7 function| onPlayerStateChange7 undefined| script object| _sf_async_config number| _sf_startpt object| _cb_shared object| __core-js_shared__ object| RTVEmbedder object| RCOM_Data object| google_optimize function| webpackJsonp object| _cbm object| YT object| YTConfig function| onYTReady object| core object| scrollMonitor object| gptadslots object| googletag function| admantx_callback object| evidon function| __cmp function| renderComponent function| ZNRKBdd object| icbue336Flags string| icbue313Rnd function| ZNRKBTrkFailed object| icbued0b3tc function| commonPopup boolean| icbue61dsdl boolean| icbue61dsdln string| icbued0b3genat string| icbued0b3sthash boolean| icbuef0fforceimp function| hj object| _hjSettings object| article_date object| author string| content_channel object| keywords object| tp boolean| icbueb99Body object| yt function| ytDomDomGetNextId object| ytEventsEventsListeners object| ytEventsEventsCounter string| NativeAIObject function| nativeAI function| _fbq function| fbq function| normalize object| TRUE_ANTHEM function| e number| abp object| _comscore function| getValuesGWIQ function| ___tp object| localCookieStorage object| sessionCookieStorage object| jQuery112408226605423506008 string| __tpVersion string| segment_user_id function| udm_ object| ns_p object| COMSCORE string| article_platform string| article_edition object| nativeAIWebpackJsonp function| ns360 object| News360 object| NativeAI object| advBidxc function| _mR function| _mD object| _mnHM object| __iasPET function| iasDataHandler string| TB4M82W string| T645KQG object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken number| google_srt undefined| google_measure_js_timing boolean| google_noFetch number| __google_ad_urls_id function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter function| googleCompanionsServicePresent function| googleGetCompanionAdSlots function| googleSetCompanionAdContents function| google_show_companion_ad function| google_show_companion_ad_in_slot function| google_get_companion_slot_params function| google_companion_error function| google_companion_loaded function| google_increment_num_ad_mouseovers string| google_ad_output string| google_flash_version boolean| google_webgl_support string| google_ad_section string| google_country string| TF6129H string| dianomiContextHost function| dianomiLoadContext function| dianomiContextSetHeight function| dianomiContextSetWidth function| dianomiContextSetFloat function| dianomiContextElement function| dianomiReloadContext function| dianomiContextReady object| hjSiteSettings function| hjBootstrap object| hjBootstrapCalled object| lazyLoadOptions number| google_unique_id object| google_reactive_ads_global_state function| _extends function| LazyLoad object| diagPixSentCodes object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| teadsscript object| teads object| Moat#G26 boolean| Moat#EVA object| MoatSuperV26 object| DOMlessLLDcallback_36074752 object| MoatDataJsonpRequest_36074752 undefined| GLOBAL_VAR undefined| ct undefined| et undefined| hourElapsed undefined| msg undefined| pixelDomain undefined| isDomless undefined| documentReferrer undefined| isBeta undefined| viewHash undefined| pxSrc undefined| px object| Moat#PML#26#1.2 object| BrandSafetyNadoscallback_96489799 object| __IntegralASExec number| _sf_endpt object| adobeDil object| adobe function| Visitor function| DIL object| s_c_il number| s_c_in string| topic_channel string| channel string| content_type string| adblock string| edition string| platform string| keyword_slug string| content_title string| inline_type string| dcontent_channel string| channel_list object| admp_vars function| getCookie object| pSUPERFLY_mab object| _cbq object| pSUPERFLY object| pSUPERFLY_video object| _cbv_strategies object| _cbv string| state object| __onetag object| __connect

0 Cookies

19 Console Messages

Source Level URL
Text
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
BODY ITEMS [object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/markets?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/world?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/politics?count=7
console-api log (Line 1)
Message:
Blocking Ads: No
console-api log (Line 1)
Message:
comscore new global fired
console-api warning URL: https://connect.facebook.net/en_US/fbevents.js(Line 24)
Message:
[Facebook Pixel] - Unable to parse JSON-LD tag. Malformed JSON found: ' { "@context": "http://schema.org", "@type": "NewsArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda-idUSKBN1WW0M8" }, "headline": "AstraZeneca breast cancer treatment gets FDA priority review", "url": "https://www.reuters.com/article/us-astrazeneca-cancer-drug-fda-idUSKBN1WW0M8", "image": { "@type": "ImageObject", "url": "https://s4.reutersmedia.net/resources/r/?m=02&d=20191017&t=2&i=1441765313&w=1200&r=LYNXMPEF9G0F8", "width": "800", "height": "800" }, "thumbnailUrl": "https://s4.reutersmedia.net/resources/r/?m=02&d=20191017&t=2&i=1441765313&w=1200&r=LYNXMPEF9G0F8", "dateCreated": "2019-10-17T07:20:45+0000", "dateModified": "2019-10-17T07:20:45+0000", "datePublished": "2019-10-17T07:20:45+0000", "author": { "@type": "Person", "name": "Reuters Editorial" }, "publisher": { "@type": "Organization", "name": "Reuters", "logo": { "@type": "ImageObject", "url": "https://s3.reutersmedia.net/resources_v2/images/reuters_social_logo.png", "width": "200", "height": "200" } }, "description": 'AstraZeneca Plc said on Thursday that the U.S. drug regulator will give a speedy review to its experimental breast cancer treatment, which could put the British drugmaker in direct competition with bigger rival Roche Holding AG.', "articleSection": "Homepage", "creator": ["Reuters Editorial"], "keywords": ["US","ASTRAZENECA","CANCER","DRUG","FDA","Performance / Results / Earnings","Company News","Health / Medicine","Japan","Western Europe","Content produced in Bangalore","Breast Cancer","Products / Services","Cancer","Sweden","Asia / Pacific","Europe","Pharmaceuticals and Medical Research (TRBC)","Science","Medical Regulatory Issues","Regulation","United Kingdom","United States", "Article", "Health"], "about":"Article" } '.
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
Require Evidon Consent: true consent: false undefined
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
Setup media.net with GDPR applied, user not consent
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
GPT SET NON PERSONAL
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
GPT ENABLE SERVICES
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/jp_bizdev_update-44668d93/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api debug URL: https://static.adsafeprotected.com/sca.17.4.95.js(Line 32)
Message:
a: 0.001708984375ms
console-api log (Line 2)
Message:
segment identify user with traits: [object Object]

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

a.teads.tv
ad.doubleclick.net
adservice.google.com
adservice.google.de
api.segment.io
async01.admantx.com
beacon.s-onetag.com
beacon.tru.am
c.evidon.com
cdn.adsafeprotected.com
cdn.native.ai
cdn.segment.com
cdn.tinypass.com
cdneast2-xch.media.net
cdnjs.cloudflare.com
cmp.teads.mgr.consensu.org
connect.facebook.net
contextual.media.net
dfp-gateway.s-onetag.com
dpm.demdex.net
dt.adsafeprotected.com
evidon.mgr.consensu.org
experience.tinypass.com
gcdn.2mdn.net
geo.moatads.com
get.s-onetag.com
gwiqcdn.globalwebindex.net
iabmap.evidon.com
l.betrad.com
mab.chartbeat.com
mailview.bulletinhealthcare.com
mb.moatads.com
pagead2.googlesyndication.com
ping.chartbeat.net
pixel.adsafeprotected.com
px.moatads.com
queso-cdn.prod.reuters.tv
r3---sn-4g5e6nsr.c.2mdn.net
reutersdfpcw319687550988.s.moatpixel.com
s.mnet-ad.net
s.ytimg.com
s1.reutersmedia.net
s4.reutersmedia.net
sb.scorecardresearch.com
script.hotjar.com
securepubads.g.doubleclick.net
sope.prod.reuters.tv
static.adsafeprotected.com
static.chartbeat.com
static.hotjar.com
static.reuters.com
stats.g.doubleclick.net
sync.teads.tv
t.teads.tv
tpc.googlesyndication.com
tru.am
vars.hotjar.com
vendorlist.consensu.org
wireapi.reuters.com
www.dianomi.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.reuters.com
www.youtube.com
z.moatads.com
dpm.demdex.net
gwiqcdn.globalwebindex.net
ping.chartbeat.net
104.18.136.13
104.244.39.20
13.224.196.39
13.225.78.43
13.225.78.67
143.204.101.109
143.204.99.83
147.75.100.189
147.75.84.99
147.75.85.25
172.217.16.162
172.217.21.198
18.204.31.32
199.166.0.26
199.166.0.32
2.18.232.7
2.18.235.40
2.18.235.93
2.21.37.179
23.43.115.95
23.45.108.200
23.62.140.165
2600:1f18:624f:b001:7dda:c8b8:5b29:d2ec
2600:9000:200d:5c00:18:1fcd:349:ca21
2600:9000:20eb:4e00:1e:ef1b:aa40:93a1
2600:9000:20eb:5800:1f:287:d20a:ce1
2600:9000:2156:5c00:5:9a4c:9b00:93a1
2600:9000:2156:7000:18:1fcd:349:ca21
2600:9000:2156:c600:a:52eb:a100:93a1
2600:9000:21f3:d400:10:27b4:f500:93a1
2600:9000:21f3:ee00:1:af78:4c0:93a1
2606:4700:20::6819:a222
2606:4700::6810:4c33
2606:4700::6813:c497
2a00:1450:4001:63::8
2a00:1450:4001:800::2002
2a00:1450:4001:80b::200e
2a00:1450:4001:818::2004
2a00:1450:4001:819::2003
2a00:1450:4001:81a::2002
2a00:1450:4001:81a::2008
2a00:1450:4001:81b::200e
2a00:1450:4001:81e::2001
2a00:1450:4001:81e::200e
2a00:1450:4001:821::200e
2a00:1450:400c:c00::9b
2a02:26f0:6c00:292::2c92
2a03:2880:f007:8:face:b00c:0:1
2a03:2880:f107:83:face:b00c:0:25de
2a04:4e42:1b::714
3.8.11.1
35.165.44.215
35.174.78.7
35.176.11.103
52.41.107.235
54.228.221.127
54.230.95.91
66.81.204.228
69.174.55.131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